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 i 
Abstract 
Protein complementation assays (PCAs) utilising two fragments of a reporter 
protein – fused to two potentially interacting proteins of interest – are a common 
method of analysing protein-protein interactions (PPIs). This approach, using split 
dihydrofolate reductase (DHFR) as a reporter protein, has been previously carried 
out for cytosolic Saccharomyces cerevisiae proteins. The focus of this study was 
to establish a split-DHFR assay specifically for use in analysing yeast mitochondrial 
PPIs in the intermembrane space (IMS), which has not been done before. A 
strategy to overcome the problem endogenous DHFR activity had to be developed 
using a modified strain of S. cerevisiae for the specific application here. Further, 
plasmids containing two positive control proteins, Tim9 and Tim10 (two well-
known interacting proteins of the IMS) were cloned for transformation into yeast 
strain BY4741. Several other plasmids bearing various control proteins were 
designed and some of them cloned, although we required more time to have the 
full set of tools to establish the assay. 
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1. Introduction 
1.1 Protein Complementation Assays (PCAs) 
1.1.1 PCAs and the Study of Protein-Protein Interactions (PPIs) 
The study of protein-protein interactions (PPIs) is vital, not only for dissecting the 
function of new genes discovered during genome sequencing, but also for the 
study and treatment of diseases. Protein Complementation Assays (PCAs) are of 
great importance in studying PPIs, functioning through the fusion of two, 
complementary fragments of a reporter protein to two proteins of interest (Figure 
1). If these two proteins interact, the reporter fragments are brought together so 
that they can now fold into their native structure and reconstitute their function 
(Remy et al., 2007). Many different PCAs approaches exist, and so the functioning 
reporter protein can give a detectable signal as colour (β-lactamase (Galarneau 
et al., 2002)), fluorescence (green fluorescent protein (GFP), bimolecular 
fluorescence complementation (BiFC)) (Hu & Kerppola, 2003; Kerppola, 2006), 
bioluminescence (Luciferase (Kaihara et al., 2003; Villalobos et al., 2007)) or even 
cell survival (dihydrofolate reductase (DHFR) (Pelletier et al., 1998)). Unlike other 
techniques such as Yeast Two-Hybrid (Y2H) screens, which require fusion proteins 
to be imported into the cell nucleus (Fields & Song, 1989), PCAs are advantageous 
as they can be used in any cellular compartment. They can also be used to study 
the formation of complexes containing three proteins, whereas Y2H screens are 
limited to binary protein complexes (Morell et al., 2009). 
 2 
Figure 1 – General Protein Complementation Assay (PCA) approach (adapted from 
Remy et al., 2007). When Protein X and Protein Y interact, PCA fragments 1 and 
2 are also brought together and native folding of the reporter protein occurs. 
This results in reconstituted reporter activity, which may be colour (β-lactamase), 
fluorescence (green fluorescent protein (GFP)), bioluminescence (Luciferase) or 
cell survival (dihydrofolate reductase (DHFR)). 
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As these PPIs can be directly detected in vivo, unlike with in vitro techniques such 
as affinity purification and mass spectrometry (AP/MS), they can be studied in the 
native environment of the proteins, which can influence their interactions with 
one another. The general approach of AP/MS involves using a cell lysate containing 
a protein of interest (‘bait’) bound to a tag, which is passed through an affinity 
column with a resin that will specifically bind to the tag. Multiple such tags exist, 
including TAP (as used in tandem affinity purification (Rigaut et al., 1999)), FLAG 
(Ho et al., 2002), hexahistidine (His) (Lichty et al., 2005), glutathione S-
transferase (GST) (Smith & Johnson, 1988), human influenza haemaglutinin (HA) 
(Moon et al., 2012) and c-Myc (Hillman et al., 2001). The column is then washed 
to remove unbound proteins and the bait protein can be eluted along with any 
interacting proteins (‘preys’) (Gingras et al., 2007). The eluted protein complex 
is digested into smaller peptide fragments with trypsin and separated using either 
liquid chromatography (LC) (Wu & MacCoss, 2002) or gel-purified via SDS-PAGE 
(Nesvizhskii, 2012). These fragments are then identified via a mass spectrometer 
to generate MS spectra that can be compared to an online database of known 
peptide sequences. The results are generated as a list of proteins (the bait and 
interacting preys), i.e. potential PPIs. AP/MS is known to give false positives due 
to incorrect identification of interacting proteins (Nesvizhskii, 2010) and non-
specific binding partners (such as heat shock proteins, ribosomal proteins, etc.) 
(Nesvizhskii, 2012), and true interactors with the bait can be less than 10% of 
those identified via MS in single-step AP (Trinkle-Mulcahy et al., 2008). Techniques 
such as Y2H and AP/MS, however, can often be used to complement the PCA 
approach and provide the initial data for potential PPIs (Remy et al., 2007). PCAs 
can then be used to study the localisation of these proteins, or even competition 
for binding to a specific protein (Morell et al., 2009). Full-length proteins of 
interest can be fused to the reporter fragments, although care must be taken to 
ensure the fragments do not interfere with protein targeting or post-translational 
modifications through their fusion to the N- or C-terminal domain (Remy et al., 
2007). Linker sequences – of around 10-15 amino acids – are often added between 
the reporter and protein of interest. This is done to ensure that the reporter 
fragments are able to efficiently fold back into their native structure together, 
without being hindered by the size of the interacting proteins (Michnick et al., 
2010). 
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Of all PCAs, fluorescent proteins – split-GFP (and its derivatives, such as BiFC) – 
are among the most widely used, with fluorescent signal strength indicating the 
strength of the PPI. High expression of the fluorescent reporter fragments can, 
however, result in association of the two fragments independent of the PPI (Morell 
et al., 2009). Split-GFP also interacts irreversibly, which can cause trapping of 
non-specific complexes and the disruption of endogenous PPIs (Tarassov et al., 
2008). Another PCA, Luciferase, is reversible, but requires the addition of a 
substrate to provide its bioluminescent signal (Morell et al., 2009). Split-DHFR is 
also reversible, and useful in large-scale studies of PPIs – where it can be used to 
screen a cDNA library for potential interacting partners of a particular protein 
(Tarassov et al., 2008). Split-DHFR also has a distinct advantage in that is does not 
require any specialist equipment to visualise the results, as PPI is indicated by cell 
growth and not, for example, by fluorescence (which requires fluorescent 
microscopes to analyse) (Remy et al., 2007). These three PCAs – GFP, Luciferase 
and DHFR – are compared in Table 1. 
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Table 1 – Comparison of Protein Complementation Assays (PCAs) (adapted from 
Michnick et al., 2010). Protein mass for dihydrofolate reductase (DHFR), green 
fluorescent protein (GFP), Renilla reniformis Luciferase (Rluc) and Gaussia 
princeps Luciferase (Gluc) were taken from UniProt (Consortium, 2017). 
  
Reporter 
Protein 
SIgnal 
Mass 
(kDa) 
Reversible? Advantage(s) Disadvantage(s) 
DHFR cell growth 21.6 Yes 
no specialist 
equipment 
required for 
visualisation 
endogenous 
DHFR present in 
many cell types 
GFP fluorescence 26.9 No 
stability of 
fragment 
interaction 
allows 
detection of 
transient PPIs 
signal detection 
inhibited by 
background 
fluorescence of 
cell 
Luciferase bioluminescence 
36.0 
(Rluc) 
19.9 
(Gluc) 
Yes 
can be 
measured on 
the timescale 
of seconds 
substrates 
required 
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1.1.2 Dihydrofolate Reductase (DHFR) as a PCA 
DHFR (Figure 2A) is an enzyme that catalyses the synthesis of hydrofolate to allow 
for nucleotide biogenesis, via the reduction of dihydrofolic acid (DHF) to 
tetrahydrofolic acid (THF) (Michnick et al., 2010) (Figure 2B). DHFR uses NADPH 
as a co-factor in this reaction, wherein it acts as an electron donor and is 
converted to NADP (Remy et al., 2007). DHFR has 3 domains, the discontinuous F1 
and F3 domains, and the adenine-binding domain F2 (Pelletier et al., 1998). Both 
the substrate-binding pocket and NADPH-binding groove of DHFR are formed 
mainly by residues in the F2 and N-terminal portion of F1. Residues 101-108 form 
a disordered loop which can be disrupted with no significant effect on DHFR 
activity (Pelletier et al., 1998). This was first shown In 1992, when the loop was 
removed from murine DHFR (mDHFR) through circular permutation and the new 
variant was found to differ very little in terms of functionality (Buchwalder et al., 
1992). 
The split-DHFR PCA has been established not only in Escherichia coli (Pelletier et 
al., 1999; Pelletier et al., 1998) and Saccharomyces cerevisiae (yeast) cells – which 
will be discussed in detail later – but also mammalian cell lines (Michnick & Remy, 
1999) and plant protoplasts (Subramaniam et al., 2001). The first of these studies 
was carried out in 1998, when Pelletier et al. showed that DHFR can be 
reassembled from complementary fragments (F1/2 and F3) when fused to 
interacting proteins. Due to its role in hydrofolate synthesis, DHFR activity is 
required for growth on minimal media lacking complex nutrients. E. coli DHFR is 
more sensitive to inhibition via trimethoprim than mDHFR. Trimethoprim is an 
anti-folate drug which binds to DHFR and inhibits the reduction of DHF to THF 
(Brogden et al., 1982). In Pelletier et al.’s study, mDHFR fragments were fused to 
interacting proteins in E. coli cells, which were then grown on minimal media in 
the presence of trimethoprim. The trimethoprim levels were high enough to 
inhibit the endogenous DHFR but not mDHFR, allowing only for the growth of cells 
where interacting proteins allowed for the reconstituted, mDHFR to assemble in 
a functional form. This approach allowed for the development of this technique 
as a general method for detecting protein-protein interactions in vivo via an 
enzyme-based detection system. 
 7 
 
Figure 2 – Dihydrofolate reductase (DHFR) structure and function. A: Structure of 
DHFR (Ulrich et al., 2007). The adenosine-binding domain is highlighted in red. B: 
Comparison of Dihydrofolate (DHF) and Methotrexate (MTX) (Zheng & Kwon, 
2013). DHFR reduces its substrate, DHF, to Tetrahydrofolate (THF) via NADPH. 
MTX is able to act as a competitive inhibitor of DHF due to its similar structure. 
Differences in the chemical structure of MTX compared to DHF are circled. 
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A modified approach to this assay was undertaken for use in mammalian cells. In 
1980, a cell line derived from Chinese hamster ovaries (CHO) with no endogenous 
DHFR activity was generated (CHO-DUKX-B11) (G Urlaub & Chasin, 1980). This 
DHFR-negative cell line  was used alongside fusion proteins with mDHFR fragments 
(Israel & Kaufman, 1993; Michnick & Remy, 1999). In this approach, it was shown 
that only 25 protein complexes per cell are needed for the split-DHFR assay to 
work (Michnick et al., 2010). The CHO-DUKX-B11 cell line, however, is prone to 
reverting to functional DHFR activity when mutagenised (G Urlaub & Chasin, 1980), 
and so a completely DHFR-deficient strain known as CHO-DG44 has also been 
developed via deletion of both DHFR alleles (Gail Urlaub et al., 1983). Mammalian 
cells with DHFR activity can also be used as an alternative approach to the split-
DHFR PCA, via the use of mutated mDHFR fragments with a resistance to 
methotrexate (MTX) (Thillet et al., 1988). MTX, an anti-folate drug, can act as a 
competitive inhibitor of DHFR binding in its active site (i.e. as a DHF analog) 
(Figure 2B). The native DHFR is therefore inhibited by the MTX, but complemented 
by the activity of the reconstituted, mutant mDHFR fragments (Remy et al., 2007). 
1.1.3 Split-DHFR in Yeast 
Saccharomyces cerevisiae has a DHFR homologous gene, DFR1, which is localised 
to the cytoplasm and mitochondria (Huh et al., 2003) and is essential for viability. 
This presents an issue for the use of DHFR as a PCA in S. cerevisiae, as the 
endogenous DFR1 is necessary for cell growth but will interfere with the assay. 
With this in mind, in 2008 two groups took different approaches to adjust the split-
DHFR assay for use in S. cerevisiae cells (Shibasaki et al., 2008; Tarassov et al., 
2008). The first of these approaches, carried out by Shibasaki et al., used a 
combination of trimethoprim and sulphanilamide to inhibit the endogenous DHFR 
precursor. Sulphanilamide enhances the sensitivity of S. cerevisiae cells to 
trimethoprim, as the DHFR homolog present is not as sensitive to the drug as E. 
coli DHFR. mDHFR, which, as noted previously, has a lower affinity for 
trimethoprim, was used as the reporter protein fragments fused to the proteins 
of interest and was therefore able to complement for the lack of DFR1 activity. 
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Tarassov et al., 2008, however, undertook a different approach based on a MTX-
resistant mutant of mDHFR fragments. They carried out site-directed mutagenesis 
to insert a L22F mutation into the mutant F31S mDHFR F1/2 fragment originally 
used in a mammalian cell split-DHFR assay (Michnick & Remy, 1999). By mutating 
two amino acids in the F1/2 fragment (L22F and F31S) (Figure 3), the reconstituted 
mDHFR remains active but becomes 10,000 times less sensitive to MTX than DFR1 
(Ercikan-Abali et al., 1996). Therefore, when grown in the presence of MTX, the 
endogenous DFR1 is inhibited by the drug, whereas the MTX-resistant mDHFR 
fragments are not able to complement its function when protein complementation 
of the fragments occurs. Tarassov et al. used this approach to set up a large-scale 
genome-wide screen in S. cerevisiae cells. They achieved this by creating universal, 
DHFR fragment cassettes which were then used to create homologous 
recombination cassettes for 5756 genes in S. cerevisiae haploid strains. Open 
reading frames (ORFs) fused to the mutant F1/2 fragment of mDHFR were inserted 
into MATa strains and then mated to MATα strains containing ORFs fused to the F3 
fragment. Diploid strains containing reconstituted mDHFR were selected for on 
minimal media with MTX present, with PPIs analysed via the size of any colony 
growth. 
 10 
Figure 3 – Murine Dihydrofolate Reductase (DHFR) sequence (adapted from Remy 
et al., 2007; Tarassov et al., 2008). Fragment 1 (F1/2) of the split-DHFR approach 
is highlighted in blue and fragment 2 (F3) in red. The corresponding residues 
which were mutated in Tarassov et al.’s approach to create a Methotrexate (MTX) 
resistant strain of DHFR are indicated in yellow. 
  
 11 
1.2 Protein Import into Yeast Mitochondria 
 1.2.1 Mitochondria and Protein Import 
Mitochondria (Figure 4) are double-membraned organelles with an outer 
membrane (OM) acting as a barrier between mitochondria and the cytosol, and an 
inner membrane (IM) (Riemer et al., 2011). The surface area of the IM can be more 
than four times greater than that of the OM, due to invaginations in its structure 
known as cristae (Ikon & Ryan, 2017). The IM separates the two, main 
compartments of mitochondria known as the intermembrane space (IMS), where 
oxidative protein folding occurs, and the matrix. The IMS has been shown to be 
further organised into two, distinct regions – the ‘bulk’ of the IMS defined by the 
inner boundary membrane (IBM), and the cristae lumen (Ikon & Ryan, 2017). 
Cytochrome C (CytC) and the oxidative phosphorylation complexes, involved in 
the electron transfer reactions of respiration, are sequestered from the rest of 
the IMS in these cristae junctions (Perotti et al., 1983; Scorrano et al., 2002).  
95% of mitochondrial protein precursors are encoded by the nucleus and 
synthesised in the cytosol before their import into mitochondria (Fraga & Ventura, 
2013). In humans, mitochondrial DNA only encodes 13 mitochondrial polypeptides 
(Sickmann et al., 2003). Mitochondrial proteins can be destined for any 
compartment of mitochondria, including not only the IMS and matrix but also the 
OM and IM. It is therefore important to understand the various import pathways 
that these mitochondrial proteins undertake (Figure 6). 
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Figure 4 – Structure of mitochondria and metabolism organisation (Ikon & Ryan, 
2017). Glucose, fatty acids and amino acids provide the acetyl CoA which allows 
for the tricarboxylic acid (TCA) cycle to occur in the mitochondrial matrix. 
Electron transfer from Oxidised NADH and FADH2 from the TCA cycle is then used 
to create an electron transfer gradient across the cristae membrane (via H+ ions) 
which drives the production of ATP. 
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1.2.2 Protein Import Pathways 
  1.2.2.1 Targeting Signals and Chaperones 
Due to being synthesised in the cytosol, mitochondrial proteins require both 
targeting signals and chaperones to ensure that they are imported to the correct 
subcompartment of mitochondria. Specific targeting of mitochondrial preproteins 
to different subcompartments is determined based on targeting sequences found 
within them (Chatzi et al., 2016). For example, an N-terminal presequence known 
as the mitochondrial targeting sequence (MTS) will target preproteins to the 
matrix unless they contain a further internal targeting sequence (Manganas et al., 
2017). The MTS is an amphipathic α-helix that is normally cleaved following 
preprotein import by the mitochondrial processing peptidase (MPP) (Braun & 
Schmitz, 1997). Cytosolic chaperones such as heat shock protein (Hsp) 70 and 90 
prevent the aggregation of mitochondrial protein precursors and aid in their 
translocation to the general import pore of mitochondria – the TOM (translocase 
of the OM) complex (MacPherson & Tokatlidis, 2017; Neupert & Herrmann, 2007). 
The IMS also contains ATP-independent mitochondrial chaperones known as the 
small Tim family which aid in the translocation of polytopic IM and OM proteins 
that do not contain a targeting presequence (Chan et al., 2006). In S. cerevisiae 
two such small Tim complexes function alongside the TIM22 (translocase of the 
inner membrane 22) and SAM (sorting and assembly machinery) complexes to 
chaperone mitochondrial proteins (MacPherson & Tokatlidis, 2017). These are 
known as the TIM9/10 and TIM8/13 complexes, which form hexameric structures 
with 3 protomers of Tim9-Tim10 or Tim8-Tim13, respectively (Beverly et al., 2008; 
Webb et al., 2006). 
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Figure 5 – Routes of protein import into mitochondria (adapted from Manganas 
et al., 2017). Precursor proteins are chaperoned through the cytosol, by heat 
shock protein (hsp) 70 and 90, to the general import pore of mitochondria, the 
translocase of the outer membrane (TOM) complex. A: Import into the outer 
membrane (OM). After their translocation through the TOM complex, precursor 
proteins are chaperoned through the intermembrane space (IMS) by the TIM9/10 
complex. They are targeted to to the sorting and assembly machinery (SAM) 
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complex for insertion into the OM via the β-barrel pathway. B: Import into the 
inner membrane (IM). Precursor proteins are chaperoned by the TIM9/10 complex 
to the TIM22 (translocase of the inner membrane 22) complex for insertion into 
the IM via the carrier pathway. C: Import into the matrix. Precursor proteins are 
inserted into the matrix by TIM23 with translocation driven by the presequence 
translocase-associated motor (PAM) complex. The protein is then cleaved by the 
mitochondrial processing peptidase (MPP). D: Import into the IMS. Import into 
the IMS is carried out via the stop-transfer pathway and TIM23, with cleavage of 
precursor proteins by the inner membrane protease (IMP) and MMP. Proteins may 
also follow the Mitochondrial IMS Assembly (MIA) pathway and become trapped 
in the IMS via oxidative folding carried out by electron transfer between Mia40, 
Erv1 and Cytochrome C (CytC).  
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  1.2.2.2 Outer Membrane (OM) 
The general import pore of the OM, the TOM complex, has two receptors – Tom20 
and Tom70 – which have hydrophilic domains exposed to the cytosol that interact 
with mitochondrial substrate proteins (MacPherson & Tokatlidis, 2017). Tom20 and 
Tom70 can compensate for one another’s functions (Neupert & Herrmann, 2007), 
though Tom20 interacts with the hydrophobic residues of N-terminal presequences 
(i.e. the MTS) of incoming precursor proteins via its binding groove (Abe et al., 
2000) and Tom70 recognises hydrophobic precursors with internal targeting 
sequences (Chan et al., 2006). Tom71 is a paralogue of Tom70 and can also 
partially compensate for its function (P. Rehling, 2003; Webb et al., 2006). Unlike 
Tom20 and Tom70 which are imbedded in the OM by their N-terminal domains, 
Tom22 exposes its N-terminus to the cytosol and its C-terminus to the IMS (van 
Wilpe et al., 2000). Tom22 connects Tom20 to the pore of TOM and has a large 
IMS domain that aids later translocation stages from the OM to the IM (MacPherson 
& Tokatlidis, 2017; Wagner et al., 2008). The central channel, Tom40, acts as the 
binding regions for precursor proteins (Neupert & Herrmann, 2007; Shiota et al., 
2015) and Tom5, Tom6 and Tom7 modulate interactions with the channel (with it 
being lethal when all 3 channel modulating genes are deleted) (Dekker et al., 
1998; Dietmeier et al., 1997; Sherman et al., 2005). 
The TOM complex, along with the SAM complex, is also involved in the insertion 
of proteins to the OM (MacPherson & Tokatlidis, 2017) (Figure 5A). Some OM 
proteins need other complexes for their import into the OM, whereas β-barrel 
proteins are guided by a conserved β-signal (as they lack a MTS) as well as a 
conserved β-hairpin structure which is recognised by Tom20 (Bohnert et al., 2010; 
Hildenbeutel et al., 2012). The SAM complex also inserts proteins in the OM, and 
has a main component – Sam50 – which is highly conserved as well as 2 hydrophilic 
subunits exposed at its cytosolic side, Sam35 and Sam37 (MacPherson & Tokatlidis, 
2017). Sam50 and Sam35 are essential, and Sam35 recognises the β-signal in β-
barrel protein insertion and opens the Sam50 channel (Bohnert et al., 2010). 
Sam37, however, has been shown to be essential for the formation of the TOM-
SAM complex during the insertion of OM proteins (Neupert & Herrmann, 2007). 
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  1.2.2.3 Inner Membrane (IM) and Matrix 
Polytopic proteins (with multiple transmembrane domains) follow the carrier 
pathway and are inserted into the IM via TIM22 (Hasson et al., 2010) (Figure 5B). 
The TIM22 pathway requires itself, the small Tims (specifically, the TIM9/10 
complex) and the TOM complex in order to function. The Tim22 subunit makes up 
the main insertion channel, with conserved cysteine residues that stabilise Tim22 
and are vital to its function (Davey et al., 2006). TIM22 also has accessory subunits 
Tim18 and Tim54, with Tim54 being non-essential (Kerscher et al., 1997; 
Kovermann et al., 2002). 
Import into the mitochondrial matrix via TIM23 (Figure 5C) is similar to the carrier 
protein import pathway, but uses the TIM8/13 complex to chaperone preproteins 
instead of TIM9/10 (Paschen et al., 2000). The Tim23 subunit is the main channel 
and has an IMS domain receptor for presequences of incoming proteins (Kozany et 
al., 2004; Li et al., 2004). Tim50, on the other hand, interacts with mitochondrial 
precursor proteins via the IMS C-terminal domain of TIM23 (Geissler et al., 2002; 
Mokranjac et al., 2003; Yamamoto et al., 2002). Tim17 is also essential and 
although its function was originally unknown, it has been shown to interact with 
Pam17 of PAM (Presequence translocase-Associated Motor) complex (Jensen & 
Johnson, 2001; Peter et al., 2004; Ting et al., 2014). The PAM complex acts as the 
secondary driving force of protein import to the matrix and is powered by ATP 
hydrolysis (Bauer et al., 2000). 
  1.2.2.4 Intermembrane Space (IMS) 
IMS-targeted proteins have sequences with conserved motifs necessary for their 
import. Some contain N-terminal bipartite sequences (a MTS domain followed by 
a hydrophobic domain) and follow a variation of the TIM23 import pathway (Glick 
et al., 1992). This is known as the ‘Stop Transfer’ Pathway (Figure 5D), wherein 
precursors are stopped during translocation through the TIM23 pore due to the 
presence of a hydrophobic targeting sequence (Glick et al., 1992). The MTS is then 
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cleaved by MPP and further proteolysis of the hydrophobic domain is carried out 
in an ATP-independent manner before the protein is released into the IMS (Glick 
et al., 1992). Mgr2 (Mitochondrial genome required 2) acts as a gatekeeper in this 
process by recognising positive residues found in the matrix-targeting signal of 
incoming peptides, therefore preventing incorrect import of preproteins into the 
IMS (Ieva et al., 2014). Proteins which lack a targeting presequence follow the 
Mitochondrial IMS Assembly (MIA) pathway (Figure 5D), utilising oxidative folding 
to trap precursor proteins in the IMS (Sideris & Tokatlidis, 2010), which will be 
discussed in more detail in the next section. 
 1.2.3 Redox Regulation in Mitochondria 
  1.2.3.1 Oxidation and Protein Folding 
Mitochondria are organelles that function not only in energy production, but also 
apoptosis and iron-sulphur cluster assembly (Manganas et al., 2017). Due to their 
role within cells, mitochondria are a major source of reactive oxygen species (ROS) 
– for example when the mitochondrial respiratory chain produces hydrogen 
peroxide (H2O2) from the dismutation of the superoxide anion (O2-). ROS are 
involved in redox signalling when in low amounts but their production can also 
lead to mitochondrial dysfunction when in excess, resulting in the development 
of disease (Murphy, 2009). One such effect of ROS production is protein oxidation 
through the generation of disulphide bonds between cysteine residues (Morano et 
al., 2012). Oxidation allows cysteines to create intramolecular bonds to induce 
protein folding, or intermolecular bonds between different proteins as part of an 
interaction. Cysteines are therefore classified as either functional cysteines 
involved in the active sites of proteins, or essential structural cysteines 
maintaining the correct 3D shape of a protein (Chung et al., 2013) without a direct 
role in their function. Cysteines are less common within protein sequences than 
other amino acids. Together with other rare amino acids – tryptophan and 
methionine – they make up 5% of amino acids present in proteins, compared to 
more common amino acids, such as leucine, serine, lysine and glutamic acid, 
which together make up approximately 32% of all amino acids (Gaur, 2014; Lodish 
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et al., 2000). Cysteine residues themselves make up approximately only 2% of 
proteins (Hansen et al., 2013). Many cysteines are conserved across different 
eukaryotes, inferring that they have an important function within proteins 
(Riemer et al., 2011). This is because uncontrolled oxidation of cysteines can 
cause aberrant folding of native proteins, or indeed inactivation or modification 
of their function or regulation. It is therefore important for cells to have defence 
mechanisms against oxidation and the random formation of disulphide bonds. 
Prevention or promotion of oxidative protein folding is ensured through 
compartmentalisation within cells, not only in mitochondria – specifically, the IMS 
– but also in the endoplasmic reticulum (ER) of eukaryotes and the periplasm of 
bacteria (Riemer et al., 2011). This comparative similarity between bacterial 
periplasm and the mitochondrial IMS is likely explained by endosymbiotic theory 
and the origins of mitochondria from prokaryotes (Sideris & Tokatlidis, 2010). 
Within the IMS, there are several examples of small proteins containing cysteine 
residues that can be affected by oxidation. These include substrates of the MIA 
pathway which contain cysteine motifs (CXnC), such as the small Tims, and 
oxidoreductases such as thioredoxin (Trx). The small Tims and Trx differ in that 
small Tims must be oxidised in the IMS in order to fold and function correctly, 
whereas the opposite is true for Trx (i.e. it must stay reduced for functionality). 
In this way, they represent a varied spectrum of proteins in the IMS which differ 
in their respective redox states. 
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1.2.3.2 Oxidative Folding in Mitochondria 
The oxidative folding (or MIA) pathway of the mitochondrial IMS is centred round 
the oxidoreductase Mia40, which acts as a chaperone and a disulphide donor 
protein for imported precursors (Figure 6). The introduction of disulphide bonds 
is the catalytic event that induces their folding and traps them in the IMS (Sideris 
& Tokatlidis, 2010). Within S. cerevisiae, Mia40 is imported and inserted into the 
IM via TIM23 and bound to the membrane by its N-terminus, whereas the IMS-
exposed C-terminus of Mia40 catalyses its reaction with protein precursors (Chatzi 
et al., 2013). MIA pathway substrates contain twin CXnC (n = 3 or 9) motifs that 
associate with the hydrophobic substrate binding cleft of Mia40. Following this 
association, the substrate interacts with a conserved CPC motif, the second 
cysteine of which forms the mixed disulphide intermediate with the substrate 
protein (Chatzi & Tokatlidis, 2013). Preproteins with CX3C motifs include small 
Tims such as Tim8, 9, 10, 12 and 13, which function as chaperone protein 
complexes that aid the movement of membrane proteins through the IMS (Sideris 
& Tokatlidis, 2010). CX9C motifs, on the other hand, made up around fifty-nine 
proteins in the S. cerevisiae genome, fourteen of which are shown to localise to 
mitochondria (Gabriel et al., 2007; Longen et al., 2009). Many of these proteins 
are involved in the assembly or stability of the mitochondrial respiratory chain 
(Chatzi & Tokatlidis, 2013). 
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Figure 6 – The oxidative folding pathway in the mitochondrial intermembrane 
space (IMS) (adapted from MacPherson & Tokatlidis, 2017). Unfolded substrate 
proteins are folded by oxidised Mia40 (1), which becomes reduced as a result and 
is reoxidised through recycling by Erv1 (2). Erv1, which is reduced by this process, 
is then reoxidised by electron transfer to Cytochrome C (CytC) (3). 
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The incoming, reduced precursors interact with Mia40 by forming a mixed 
disulphide intermediate. Their release in the oxidised state results in the 
reduction of Mia40, the active site of which is recycled by Erv1, an essential, flavin 
adenine dinucleotide (FAD)-linked sulphydryl oxidase with no structural similarity 
or sequence homology to other Mia40 substrates (Chatzi & Tokatlidis, 2013). Erv1 
has three conserved cysteine pairs (C30/C33, C130/C133 and C159/C176), the first 
of which acts as the shuttle disulphide interacting with Mia40 (Chatzi et al., 2013). 
The C-terminal cysteine pair is a structural disulphide, whereas the middle pair is 
involved in an electron transfer chain. Electrons flow from Erv1 to CytC and finally 
to molecular oxygen – both of which make up the final electron acceptors of the 
MIA pathway (Riemer et al., 2011; Sideris & Tokatlidis, 2010). 
1.2.3.3 Redox Regulation in the IMS 
Eukaryotic cells have developed further defence mechanisms against aberrant 
oxidative folding via the presence of peroxidase enzymes, redox proteins – such 
as glutaredoxins (Grxs) and Trxs – and the antioxidant glutathione (GSH) (Riemer 
et al., 2011). The mitochondrial IMS is unique in that oxidative folding of imported 
proteins occurs within it, as the IMS is a more oxidising environment than the 
cytosol (Sideris & Tokatlidis, 2010). It is not well understood how the maintenance 
of different redox states between mitochondrial subcompartments occurs. Studies 
by Kojer et al., however, have shown that GSH regulation is important in this 
process. Yeast strains lacking functional GSH are more susceptible to oxidative 
stress from O2- and peroxides (Grant, 2001). Kojer et al. noted that GSH diffuses 
freely between the IMS and cytosol through porin channels, thereby influencing 
the redox state of the IMS. This diffusion of GSH does not, however, occur between 
the IMS and the mitochondrial matrix, which maintains its own independent GSH 
levels and a more reducing environment than the IMS (Kojer et al., 2012). Similarly, 
by controlling the levels of Grxs – a reducing family of enzymes that use GSH as a 
cofactor – in the IMS, oxidative folding can occur in a reducing environment (Kojer 
et al., 2015). 
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Sulphydryl groups have been noted to play an important role in the oxidative stress 
response of cells through the Grx and Trx systems (Grant, 2001). Grxs and Trxs 
are small oxidoreductases which have structural similarity, both with active sites 
containing two, conserved cysteine residues. These cysteines are vital to the 
function of both Grx and Trx, which, although they share functional similarities, 
differ in their regulation. Grx, however, is recycled by GSH and oxidised GSH 
(GSSG) is then reduced again by electron transfer via GSH reductases (Glr) and 
NADPH. Grx reduction is therefore carried out indirectly by NADPH, unlike the Trx 
recycling system where oxidised Trx is reduced by Trx reductase (Trr) and NADPH 
directly (Holmgren, 1989; Trotter & Grant, 2002; Wheeler & Grant, 2004). 
S. cerevisiae have 8 Grxs (Grx1-8) and one GSH reductase (Glr1). Grx1 and Grx2 
are cytosolic and have a role in the cellular response to oxidative stress 
(Luikenhuis et al., 1998). Double deletion mutant strains in these genes are viable, 
though a single deletion in either Grx1 or Grx2 leaves yeast cells susceptible to 
particular ROS (O2- and H2O2 respectively) (Grant, 2001). Grx3, Grx4 and Grx5 are 
conserved in bacterial to mammalian species, and differ from most Grx in that 
they only have one cysteine residue at their active sites (Grant, 2001). Grx3 and 
Grx4 are involved in intracellular iron transport and localise in the nucleus, 
whereas Grx5 is involved in iron metabolism and mitochondrial iron cluster 
assembly (Mühlenhoff et al., 2010; Rodrıguez-Manzaneque et al., 2002). Grx6 and 
Grx7 are not well characterised by known to be present in both the ER and Golgi, 
and thought to be involved in the regulation of sulphydryl oxidation in these 
compartments (Izquierdo et al., 2008; Mesecke et al., 2008). Grx8 was identified 
as a Grx-like protein by Mesecke et al. in 2008, but a later study showed that is is 
likely not involved in defence against oxidative stress (Eckers et al., 2009). 
There are 3 Trxs (Trx1, Trx2 and Trx3) in S. cerevisiae and 2 Trx reductases (Trr1 
and Trr2). Two Trx pathways have been noted in yeast – the cytosolic pathway 
involving Trx1, Trx2 and Trr1, and the mitochondrial matrix Trx pathway with Trx3 
and Trr2 (which may be involved in oxidative stress protection during respiration) 
(Miranda-Vizuete et al., 2000; Pedrajas et al., 1999; Trotter & Grant, 2005). The 
cytosolic Trx pathway is involved in the maintenance of proteins in a reduced 
state, whereas the matrix Trx pathway may be involved in oxidative stress 
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protection during respiration (Greetham et al., 2013). The redox states of these 
pathways are maintained independently (Trotter & Grant, 2005), likely due to 
their separate compartmentalisation. In 2012, the possibility of a third Trx 
pathway in the IMS arose due to the discovery of the presence of Trx1 and Trr1 in 
this compartment (Vögtle et al., 2012). Trx1 and Trr1 may therefore be involved 
in maintaining correct oxidative folding of proteins in the IMS alongside MIA 
pathway components. 
Peroxidases include peroxiredoxins (Prxs) and glutathione peroxidases (Gpxs), of 
which Prxs – first discovered as peroxide recycling enzymes by Chae et al. – are 
better understood (H Z Chae & Rhee, 1994; H Z Chae et al., 1994). S. cerevisiae 
have three Gpxs – Gpx1, 2 and 3 – all of which are found in the cytosol, but are 
also associated with different mitochondrial subcompartments. Only the 
inactivation of Gpx3 – also associated with the IMS – leads to defective H2O2 
tolerance (Inoue et al., 1999; Kritsiligkou et al., 2017; Vögtle et al., 2012). In the 
cytosol, Gpx3 acts as a redox sensor that interacts with the transcription factor 
Yap1 to activate oxidative stress response genes, such as Trx2 (Wood et al., 2004). 
The mechanism for this interaction relies on two of the three cysteine residues 
(C36, C64 and C82) of Gpx3. C36 of Gpx3 becomes sulphenylated by H2O2 and can 
then either form a mixed disulphide bond with C598 of Yap1, or an intramolecular 
bond with the resolving cysteine of Gpx3 (C82) (Delaunay et al., 2002). The 
intermolecular disulphide bond with Yap1 induces another Yap1 intramolecular 
disulphide bond. This results in a conformational change in protein that blocks its 
nuclear export signal (NES), leading to its accumulation in the nucleus and 
activation of stress response genes (Wood et al., 2004). Unlike its known function 
in the cytosol, there is currently no established role for Gpx3 within the 
mitochondrial IMS. It is also unknown how Gpx3 is targeted to the IMS, as the 
Tokatlidis lab has unpublished data showing that it does not require the MIA 
pathway (Tokatlidis, 2016). Gpx3 has been shown to be alternatively translated 
with an eighteen amino acid N-terminal extension under oxidative (H2O2) stress 
conditions (Gerashenko et al. 2012). Work from the Tokatlidis group has shown 
that both of these forms of Gpx3 are found in the IMS, and mitochondrial Gpx3 
levels increased following treatment with H2O2. Gpx3 has also been shown to 
reoxidise Mia40, a protein involved in the oxidative folding of proteins in the IMS 
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(Kritsiligkou et al., 2017). As such, a possible hypothesis is that the N-terminal 
extension of Gpx3 improves its targeting into the IMS, where it is involved in an 
oxidative stress response to prevent H2O2 damage to proteins and aid in the 
correct functioning of the MIA pathway (Tokatlidis, 2016). 
1.3 Focus of this Study 
1.3.1 Study of PPI in Mitochondria 
PPIs studying the different import pathways of mitochondrial proteins have 
traditionally been shown through pull down assays. The different 
subcompartments of mitochondria, however, mean that this approach is not 
always ideal. The study of IMS proteins is considered difficult as it is a constricted 
space with few proteins, and therefore much more material would be required to 
successfully carry out a successful pull down assay. IMS protein localisation has 
also been suggested by confocal GFP fluorescence in many studies, but this is not 
a reliable approach due to the large size of GFP (Table 1). The constrictive nature 
of the IMS also makes the GFP approach difficult, as an OM-localised protein in 
the cytosol or IMS could appear to co-localise based on GFP confocal microscopy. 
It is difficult to show that a given protein is indeed localised to the IMS and 
interacts with other proteins in the IMS without the creation of a stable 
intermediate for further study. This approach has been utilised in the Tokatlidis 
lab for Mia40 and its substrates by mutagenising the resolving cysteine and leaving 
the docking cysteine intact (Sideris & Tokatlidis, 2007). If a protein is imported 
into the IMS independently of Mia40, however, its localisation in vivo becomes 
more difficult to ascertain. One possible method of study would be to use a robust 
and reliable in vivo assay such as the split-DHFR PCA discussed previously. 
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1.3.2 Aims of the Project 
Although the split-DHFR PCA approach (Figure 7) has been used in yeast before, it 
has only been used to examine the interactions of cytosolic proteins, and not 
mitochondrial proteins (Tarassov et al., 2008). Therefore, the aims of the project 
are to: 
1. First, establish DHFR as a PCA technique (Figure 8) for use in proteins 
targeted to mitochondria, using control PPIs to verify that the assay can be used 
successfully. This approach could be used not only for IMS-targeted proteins, but 
also matrix proteins and even membrane proteins.  
2. Then, use the split-DHFR approach to confirm any putative interactions of 
mitochondrial proteins, that have been investigated by other PPI assays (and 
functional protein interactions). 
3. Further set up split-DHFR as a method of determining the route of import 
of mitochondrial proteins to the IMS (Figure 9). 
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Figure 7 – A simplified version of the split-dihydrofolate reductase (DHFR) 
approach in yeast. Protein X and Protein Y are fused to the two split-DHFR 
fragments, respectively, and transformed into yeast cells. When Protein X and 
Protein Y interact, DHFR is reconstituted and the activity of the protein is 
recovered to allow for cell growth (adapted from Remy et al., 2007). 
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Figure 8 – The general approach for generating the split-dihydrofolate reductase 
(DHFR) fragments for use in this study. The DHFR fragment (either F1/2 or F3) is 
cloned from a plasmid containing the full murine DHFR sequence and transformed 
into bacterial cells (1). A positive colony containing the DHFR fragment are 
selected and purified (2). For DHFR-F1/2, PCR mutagenesis is carried out to 
generate a mutated form of DHFR-F1/2 (DHFR-F1/2mut) resistant to inhibition 
by methotrexate (2A). A positive colony containing DHFR-F1/2mut is then 
selected and purified (2B). Both DHFR fragments are then transformed into yeast 
for expression (3). 
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Figure 9 – Generalised example of using split-dihydrofolate reductase (DHFR) to 
determine the route of import of a protein into the intermembrane space (IMS). 
A: In wild-type yeast, Protein X is imported into the IMS (either by ‘Import Protein 
Complex 1’ or another route). In the IMS, Protein X and Protein Y interact. Two 
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potential scenarios can occur when this knowledge is applied to the split-DHFR 
assay. In this example, this is carried out using a deletion strain for a component 
of Import Protein Complex 1, Δ Import Protein Z, which prevents import of 
Protein X into the IMS. Protein X is fused to mutated murine DHFR (mDHFR) 
fragment 1, and Protein Y to mDHFR fragment 2 – able to form mDHFR resistant 
to inhibition by methotrexate (MTX). When these two fragments are able to form 
native mDHFR via the interaction of Protein X and Protein Y, mDHFR activity is 
reconstituted. This is carried out in the presence of MTX to inhibit endogenous 
DHFR. B: Protein X is not imported into the IMS by Protein Complex 1 but by 
another, unknown route. Its import is therefore not inhibited by the lack of 
functional Import Protein Complex 1, due to the deletion of its component, 
Protein Z. Protein X and Protein Y interact in the IMS and mDHFR activity occurs, 
allowing for cell survival in the presence of MTX. C: Protein X is imported via 
Import Protein Complex 1 and therefore is unable to be imported into the IMS. 
Protein X and Protein Y therefore do not interact and no mDHFR activity occurs 
as a result. 
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2. Materials and Methods 
2.1 Transformation of Plasmids into E. coli 
2.1.1 PCR Amplification 
The primers designed were used for polymerase chain reactions (PCR) in the 
Biometra® T3 Thermocycler. The PCR reaction mixture of a single sample 
contained 2µl 10x buffer (New England BioLabs), 0.4µl dNTPs (Invitrogen), 0.5µl 
of each primer (10µM stock, Sigma), 11.4µl dH2O, 5µl (10ng/µl) template DNA and 
0.2µl Taq DNA polymerase (5000 units/ml, New England BioLabs) to make up a 
total volume of 20µl. One unit of Taq DNA polymerase is defined by New England 
BioLabs as ‘the amount of enzyme that will incorporate 15 nmol of dNTP into acid-
insoluble material in 30 minutes at 75°C’. All reaction mixtures were made up to 
20µl excluding blanks with no Taq (10µl) and large-scale reactions (300µl). 
Conditions for the PCR thermocycle varied depending on the PCR reaction being 
carried out (Table 2). 
Gene 
Amplified 
Initial 
Denaturation 
Denaturation 
Primer 
Annealing 
Extension 
Cycle 
Length 
(trial/ 
large-scale) 
Final 
Extension 
DHFR-
F1/2, 
DHFR-F3 
1 minute  
95°C 
1 minute  
95°C 
1 minute  
50°C 
3 minutes  
72°C 
25 / 35 
10 minutes  
72°C 
Tim9, 
Tim10 
1 minute  
95°C 
1 minute  
95°C 
1 minute  
58°C 
30 seconds  
72°C 
25 / 35 
10 minutes  
72°C 
Gpx3 
1 minute  
95°C 
1 minute  
95°C 
1 minute  
50°C 
1 minute  
72°C 
25 / 35 
10 minutes  
72°C 
Mia40, 
Yap1 
1 minute  
95°C 
1 minute 
95°C 
1 minute 
50°C 
2 minutes 
72°C 
25 / 35 
10 minutes  
72°C 
Table 2 - PCR thermocycle conditions. DHFR refers to dihydrofolate reductase. 
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2.1.2 DNA Gel Electrophoresis 
The results of the PCR reactions were visualised using gel electrophoresis of 1% 
agarose made from 1x TAE buffer (40mM Tris pH 8.0, 20mM acetic acid, 1mM 
EDTA) and 0.5x SYBR®Safe DNA gel stain (Invitrogen). Each gel was ran at 60V for 
50 minutes in 1x TAE buffer. A 1kb DNA ladder (Promega) was used to examine 
the relative sizes of the samples. The PCR products were cleaned using the 
Macherey-Nagel NucleoSpin® Gel and PCR Clean-up according to the 
manufacturer’s instructions. 
2.1.3 Cloning of Plasmids into E. coli 
Digestion was carried out using 1x CutSmartTM buffer (New England Biolabs), 
0.4u/µl of each restriction enzyme, approximately 40µl of PCR product (gene 
insert) or 3000ng of vector, 1x Bovine Serum Albumin (BSA; ThermoFisher 
Scientific) and dH2O to make up to a total volume of 100µl for inserts and 50µl for 
vectors. Digestions were left at 37°C for 4 hours. Following digestion, the resulting 
samples were cleaned using NucleoSpin® Gel and PCR Clean-up according to the 
manufacturer’s instructions. 
Ligation of the digested products was carried out using 1x T4 DNA ligase buffer 
and T4 DNA ligase (400000 units/ml, New England Biolabs), 1mM ATP, plasmid 
vector, gene insert and dH2O to give a total reaction volume of 10µl. One unit of 
T4 DNA ligase is defined by New England BioLabs as ‘the amount of enzyme 
required to give 50% ligation of HindIII fragments of λ DNA (5´ DNA termini 
concentration of 0.12 µM, 300- µg/ml) in a total reaction volume of 20 µl in 30 
minutes at 16°C in 1X T4 DNA Ligase Reaction Buffer’. Approximately 60ng of the 
vector was used for each reaction, but the concentration of insert used depended 
on the vector:insert ratio (with 60ng vector:22ng insert for 1:1). Ligation reactions 
were left for 2 hours RT, 1 hour 30 minutes at 25°C, 1 hour RT or 16°C overnight 
as specified. 
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The ligation mixtures were added to 100µl E. coli DH5α competent cells with 
transformation efficiency of 1 x 109cfu/µg pUC19 vector DNA (New England 
BioLabs) and left for 30 minutes on ice. The samples were then heat shocked for 
45 seconds at 42°C and then put back on ice for a further 2 minutes. 900µl Luria-
Bertani (LB) medium was added to each and left to incubate at 37°C for 1 hour. 
The cells were pelleted by 5 minutes of centrifugation at 15000g at room 
temperature (RT) and 700µl was removed. The pellet was resuspended in the 
remaining volume and plated on LB + antibiotic selection plates left to grow 
overnight at 37°C. 
2.1.4 Colony PCR 
Selected colonies were added to 50µl dH2O and this was used as the DNA template 
for the PCR reaction, carried out for 20 cycles. Conditions for the PCR thermocycle 
varied depending on the PCR reaction being carried out as in Table 2. 
2.1.5 E. coli DNA Extraction/Purification 
E. coli DNA was extracted and purified using the QIAGEN QIAprep® Spin Miniprep 
Kit (250) according to the manufacturer’s instructions. The DNA concentration of 
the samples was measured using NanoDrop® Spectrophotometer ND-1000 
(Thermo). 
2.1.6 Site-Directed Mutagenesis via PCR 
The mutagenesis primers were designed for use in the Biometra® T3 Thermocycler. 
The PCR reaction mixture of a single sample contained 5µl 10x Accuzyme Buffer 
(Bioline), 1µl MgCl2 (50mM), 2µl dNTPs (Invitrogen), 2µl of each primer (10µM stock, 
Sigma), 38µl dH2O and 5µl (10ng/µl) DNA to make up a total volume of 50µl. 1µl 
Accuzyme Enzyme (250 units/100µl) Bioline) was then added, or omitted 
 34 
altogether from control reactions. Conditions for the mutagenesis PCR 
thermocycle are shown in Table 3. 
Gene 
Mutagenised 
Initial 
Denaturation 
Denaturation 
Primer 
Annealing 
Extension 
Cycle 
Length 
Final 
Extension 
DHFR-F1/2 
2 minutes  
95°C 
1 minute  
95°C 
1 minute  
60°C 
8 minutes  
72°C 
25 
10 minutes  
72°C 
Table 3 - Mutagenesis PCR thermocycle conditions. DHFR-F1/2 refers to 
dihydrofolate reductase fragment 1. 
 
The mutagenesis PCR products were digested by the addition of 1µl DpnI 
restriction enzyme (10 units/µl) and 5µl Buffer B (Promega) to the reaction mix. 
This was followed by incubation at 37°C for an hour and a half. Following digestion, 
this reaction mixture was transformed into E. coli DH5α competent cells as 
described previously. 
2.2 Transformation of Plasmids into S. cerevisiae 
2.2.1 S. cerevisiae Genomic DNA Extraction/Purification 
3ml from an overnight culture of S. cerevisiae cells was pelleted by centrifugation 
at 15000g (RT) for five minutes, followed by washing with 500µl dH2O and 
centrifugation at 15000g (RT) for a further 5 minutes. The pellet was vortexed for 
4 minutes with 200µl lysis buffer (2% Triton X-100 (v/v), 1% SDS (v/v), 100mM NaCl, 
10mM Tris-Cl pH 8.0, 1mM EDTA pH 8.0), 200µl glass beads and 200µl phenol-
chloroform. 200µl dH2O was added and the mixture was pelleted again by 
centrifugation at 15000g (RT) for 5 minutes. The supernatant was then transferred 
to a new tube and 1ml of ice-cold ethanol was added to it and mixed by inversion. 
The mixture was pelleted by centrifugation at 15000g (RT) for 2 minutes and the 
resulting pellet left to dry at RT. 400µl dH2O and 60µg RNase A was added and the 
mixture incubated at 37°C for 10 minutes, followed by the addition of 400mM 
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ammonium acetate. 1ml ethanol was added and mixed by inversion, and left to 
incubate at -20°C for 20 minutes. The mixture was then pelleted by centrifugation 
at 15000g, 4°C for 15 minutes. The pellet was left to dry and then resuspended in 
50µl dH2O. The DNA concentration of the samples was measured using NanoDrop® 
Spectrophotometer ND-1000 (Thermo). 
2.2.2 S. cerevisiae Transformation 
Transformation of plasmids into S. cerevisiae cells was carried out as in the 
LiAc/SS-DNA/PEG Transformation method (Gietz & Schiestl, 1995), using carrier 
DNA instead of SS-DNA. 
2.2.3 Growth Curves 
S. cerevisiae cells were grown in 5ml overnight cultures of SD –uracil/-leucine. OD 
(Optical Density) was measured at 0 hours and then diluted to OD 0.8 in 5ml of 
the same media with the addition of 200µg/ml MTX. OD was measured after 1 
hour and 6 hours before being further supplemented with 100µg/ml MTX and left 
overnight (approximately 21 hours). The OD of each culture was then measured 
at 24 hour intervals and either diluted into OD 0.2 in 5ml SD-ura-leu, or left to 
grow as indicated. 
2.2.4 Spot Tests 
OD 0.5 (107 cells/ml) S. cerevisiae cells were pelleted by centrifugation at 15000g 
(RT) for five minutes and then resuspended in 500µl dH2O. Four serial dilutions of 
50µl into 450µl dH20 were carried out to give 106 cells/ml, 105 cells/ml, 104 
cells/ml and 103 cells/ml. 5µl from each of these was then spotted onto a SD-ura-
leu plate with 200µg/ml MTX added, to give 104 cells/ml, 103 cells/ml, 102 
cells/ml and 10 cells/ml, respectively.  
 36 
Results 
3.1 Cloning of DHFR Fragments 
To create the initial DHFR fragments, murine DHFR (Appendix Figure 1) from the 
pSP65-Su9-DHFR vector (created by E. Kallergi) was amplified via PCR (Figure 10). 
Primers for the first fragment (F1/2) were designed for its insertion into the 
pRS316 vector, and the second fragment (F3) for insertion into pRS415 (Table 4). 
These vectors, pRS316 and pRS415 (Appendix Figures 2 and 3), contain ampicillin 
resistance genes and also genes expressing either uracil (URA3) or leucine (LEU2), 
respectively. As seen in Figure x, each of the DHFR fragments gave expected band 
sizes of approximately 318bp (F1/2) and 243bp (F3) respectively. 
Restriction sites were chosen to leave multiple, upstream cut sites for later 
insertion of proteins of interest to be linked to the DHFR fragments, with a C-
terminal orientation of the fragments (Figure 11) as this has been shown to be the 
most efficient orientation for interaction (Remy et al., 2007). 
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Figure 10 - PCR amplification of the dihydrofolate reductase (DHFR) gene 
fragments. DHFR-F1/2 (fragment 1) and DHFR-F3 (fragment 2) sequences 
compared to a 1kb DNA ladder (M) displaying bp size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 4 - Vector, insert size and restriction sites used for the dihydrofolate 
reductase (DHFR) fragments. F1/2 refers to DHFR fragment 1 and F3 to DHFR 
fragment 2. 
Gene Vector Insert Size (bp) Restriction Sites 
DHFR-F1/2 pRS316 318 XhoI / KpnI 
DHFR-F3 pRS415 243 BamHI / XbaI 
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Figure 11 – Design of the dihydrofolate reductase (DHFR)-fragment containing 
plasmids. A: The first half of DHFR (F1/2) was inserted into the polyclonal site of 
pRS316 (purple), with an upstream protein of interest inserted for C-terminal 
expression of F1/2. pRS316 also contains ampicillin resistance (AmpR, green) and 
an uracil marker (URA3; orange) for growth on selective media. B: The second 
half of DHFR (F3) was inserted into the polyclonal site of pRS415 (purple) as in 
(A). pRS415 also contains AmpR (green) and a leucine marker (LEU2; orange) for 
growth on selective media. Different selection markers for growth on yeast media 
(URA3 and LEU2) were selected to allow the transformation of both plasmids into 
a single yeast strain for simultaneous expression of the two DHFR fragments. 
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The site for the division of full-length DHFR into two fragments was selected based 
on the work of Pelletier et al., who showed that residues 101-108 form a 
disordered loop which can be disrupted with little effect on the activity of the 
reconstituted DHFR (Pelletier et al., 1998). As well as cut sites for the relevant 
restriction enzymes, a linker amino acid sequence was also inserted to allow the 
DHFR fragments the most flexibility in both finding one another and folding 
correctly (Tarassov et al., 2008) when transformed into cells (Figure 7). 
These DHFR fragment containing vectors were cloned into E. coli cells and 
positives were selected for via ampicillin plates, colony PCR and sequencing of 
purified DNA. Positive clones were then transformed into wild-type BY4741 S. 
cerevisiae cells – a yeast deletion strain lacking genes for histidine (HIS3), leucine 
(LEU2), methionine (MET15) and uracil (URA3) (Brachmann et al., 1998). Positive 
colonies were selected for using SD minimal media and auxotrophic selection for 
either uracil (pRS316) or leucine (pRS415). Three resulting yeast strains were 
created: 
1. BY4741 pRS316-F1/2 
2. BY4741 pRS415-F3 
3. BY4741 pRS316-F1/2 + pRS415-F3 
3.2 Generation of MTX-resistant DHFR Fragments 
DHFR-F1/2 was mutated via sequential, site-directed PCR mutagenesis of the 
pRS316-F1/2 plasmid in order to create a MTX-resistant form of DHFR when the 
two fragments are reconstituted. The two sites mutated – L22F and F31S – were 
chosen based on the work of Tarassov et al., where they have been shown to 
create DHFR 10,000 times less sensitive to MTX than the wild-type (Tarassov et 
al., 2008). This mutant F1/2 (F1/2mut) was cloned into E. coli and transformed 
into S. cerevisiae cells as with the original F1/2. Two more yeast strains were 
created as a result: 
1. BY4741 pRS316-F1/2mut 
2. BY4741 pRS316-F1/2mut + pRS415-F3 
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3.3 Cloning of Control Proteins 
In order to test the functionality of the split-DHFR assay created, a series of 
control proteins were selected to be fused N-terminally to the respective DHFR 
fragments (Table 5). Mia40 and its substrate Tim10 were selected as positive 
controls to show a transient interaction between two proteins known to interact 
in the IMS. Tim9 and Tim10, which form the TIM9/10 complex, were also chosen 
as another set of positive controls, as they demonstrate a more stable interaction. 
Mia40 and Yap1, which do not interact directly, were chosen as negative controls. 
Gpx3, being dually localised in the cytosol and IMS, was selected as a model 
protein to show that the split-DHFR assay could potentially be used to identify the 
localisation of proteins difficult to determine through other assays. The genes of 
these proteins were amplified via PCR (Figure 12), giving expected band sizes (as 
described in Table 6) for each of the genes. They were then cut with restriction 
enzymes to allow them to be inserted into either the pRS316-F1/2, pRS316-
F1/2mut or pRS415-F3 plasmid (Table 6). 
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1st Interactor 2nd Interactor Control Description 
Mia40-F1/2mut Tim10-F3 
Positive  
(transient interaction) 
Tim9-F1/2mut Tim10-F3 
Positive  
(stable interaction) 
Mia40-F1/2mut Yap1-F3 
Negative  
(non-interactors) 
Mia40-F1/2mut - 
Interaction specificity  
(fragment does not 
interact with itself) 
Mia40-F1/2mut F3 
Interaction specificity  
(DHFR reconstitution 
due to protein 
interaction) 
Mia40-F1/2 Tim10-F3 
MTX selection  
(mutation necessary for 
MTX resistance) 
- - 
Empty vector  
(DHFR fragments 
necessary for MTX 
resistance) 
Mia40-F1/2mut Gpx3-F3 
Test interaction 
(putative interacting 
proteins) 
Table 5 - Control interactions to determine the functionality of the split-DHFR 
assay. Mitochondrial proteins (Mia40, Tim9, Tim10, Yap1, Gpx3) are fused to 
either the first half of dihydrofolate reductase (DHFR; F1/2), a mutated form of 
F1/2 which is resistant to inhibition by methotrexate (MTX; F1/2mut) or the 
second half of DHFR (F3). A plasmid containing one fusion protein linked to either 
F1/2 or F1/2mut can be expressed alongside another plasmid with a fusion 
protein linked to F3, allowing for expression of both halves of DHFR in the same 
system. 
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Figure 12 - PCR amplification of genes to be inserted N-terminally to the 
dihydrofolate reductase (DHFR) fragment plasmids. Sequences for Mia40, Tim9, 
Tim10, Gpx3 and Yap1 fragments compared to a 1kb DNA ladder (M) displaying 
bp size. 
 
 
Gene Vector Insert Size (bp) Restriction Sites 
Mia40 pRS316-F1/2mut 1212 BamHI / EcoRI 
Tim9 pRS316-F1/2mut 264 BamHI / EcoRI 
Tim10 pRS415-F3 282 XhoI / XmaI 
Gpx3 pRS415-F3 492 XhoI / XmaI 
Yap1 pRS415-F3 1953 XhoI / XmaI 
Table 6 - Vector, insert size and restriction sites used for the genes to be inserted 
N-terminally to the dihydrofolate reductase (DHFR) fragments. F1/2 refers to 
DHFR fragment 1 and F3 to DHFR fragment 2. 
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These control proteins were also cloned into E. coli cells and selected for via 
ampicillin plates, colony PCR and sequencing of purified DNA. Positive clones were 
obtained for both Tim9 (Figure 13) and Tim 10 (Figure 14), giving expected band 
sizes of 264bp and 282bp respectively. These positive clones were then 
transformed into wild-type BY4741 S. cerevisiae cells, with positive colonies 
selected for using SD minimal media and auxotrophic selection for either uracil 
(pRS316-F1/2mut) or leucine (pRS415-F3). This resulted in the creation of three 
more yeast strains:  
1. BY4741 pRS316-Tim9-F1/2mut 
2. BY4741 pRS415-Tim10-F3 
3. BY4741 pRS316-Tim9-F1/2mut + pRS415-Tim10-F3 
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Figure 13 - PCR amplification of the Tim9 gene. Tim9 sequences compared to a 
1kb DNA ladder (M) displaying bp size. 
 
 
 
 
 
 
 
 
 
 
Figure 14 - PCR amplification of the Tim10 gene. Tim10 fragment sequences 
compared to a 1kb DNA ladder (M) displaying bp size. 
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3.4 Growth in the Presence of MTX 
The BY4741 strain containing both Tim9-F1/2mut and Tim10-F3 was grown for 
several days in the presence of MTX, in order to assess if a positive interaction of 
the F1/2mut and F3 fragments would occur and reconstitute the DHFR protein. No 
significant difference in growth was observed between this strain and the negative 
control strains (Tim9-F1/2mut and F3, F1/2mut and F3, F1/2 and F3) (Appendix 
Table 1). The same strain was also used for spot tests on MTX plates alongside the 
negative controls strains, but no significant difference in growth was observed 
(data not shown). 
  
 46 
Discussion 
4.1 Approach 
PPIs can be studied via PCAs utilising two, complementary fragments of reporter 
proteins fused to potentially interacting proteins, which give an indicative signal 
if PPI occurs. Many such PCAs approaches exist (such as those in Table 1), and 
have therefore been used to study a wide variety of PPIs. This approach, however, 
has not previously been used to study PPIs within mitochondrial subcompartments, 
such as the IMS – which was the focus of this study. Using GFP fusions to localise 
proteins to the IMS and confocal microscopy to analyse these interactions is not 
always straightforward, due to potentially poor folding of GFP. DHFR is known to 
fold in the IMS when an entire DHFR protein is fused to a protein of interest, but 
has not been shown to fold when split and linked to two different proteins. 
To generate a split-DHFR assay for use in analysing mitochondrial protein-protein 
interactions in S. cerevisiae, the approach was similar to that of Tarassov et al., 
in that a MTX-resistant version of the split-DHFR protein was generated for use in 
yeast cells. Using MAT strains and homologous integration of the DHFR fragments 
was more advantageous in Tarassov et al.’s approach as it was a high throughput 
assay to screen for generic protein interactions (Tarassov et al., 2008). Constructs 
integrated directly into the genome are more stable, however, it would have been 
difficult to carry out the successful homologous recombination of multiple 
mitochondrial proteins fused to DHFR fragments into the yeast genome during the 
time available. Unlike Tarassov et al.’s approach, plasmids were generated 
containing multiple restriction sites before the DHFR fragments, so that the split-
DHFR assay could be prepared for any protein. This was done using yeast 
expression vectors (pRS316 and pRS415, shown in Appendix Figures 2 and 3). The 
plasmid constructs were assured to be in-frame by DNA sequencing using a T3 
promoter for pRS316 (Appendix Figure 2) and a T7 promoter for pRS415 (Appendix 
Figure 3), which was used to drive expression of the split-DHFR fusion protein for 
each of the control interactor proteins (Table 5).  
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The approach taken in this study was unique in that split-DHFR has never been 
used to assess the interaction of proteins imported into the yeast mitochondrial 
IMS before. Although this approach allowed for greater flexibility in application of 
the split-DHFR approach in the time given, as plasmid constructs are less reliable, 
integration into the genome could be considered later after the split-DHFR assay 
has been established and proteins have been shown to be properly targeted to the 
IMS. For this reason, specific mitochondrial proteins known to either interact with 
one another or not were used as positive and negative controls respectively (Table 
5) to assess the validity of the approach for use in further experiments. A test set 
of mitochondrial pairs could have also been tested in one of the established 
systems for the split-DHFR assay in yeast, as working with a previously established 
assay would have given ‘true’ positive controls. As the approach by Tarassov et al. 
used MAT strains, however, this would have been difficult to test in the given 
timeframe as this assay was not set up for mitochondrial proteins (Tarassov et al., 
2008).  
Currently, eight S. cerevisiae strains containing one or more of the DHFR 
fragments have been produced (Table 7). As mentioned previously, the pRS316-
F1/2, pRS316-F1/2mut and pRS415-F3 vectors contain multiple cut sites prior to 
the C-terminal DHFR fragment, and so can be used for N-terminal insertion of 
various proteins. Of the five mitochondrial proteins chosen to initially set up the 
split-DHFR assay – Mia40, Tim9, Tim10, Gpx3 and Yap1 – only vectors containing 
Tim9 and Tim10 were successfully cloned (Appendix Figures 7 and 8).  
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F1/2 Fragment (pRS316) F3 Fragment (pRS415) 
F/2 - 
- F3 
F1/2 F3 
F1/2mut - 
F1/2mut F3 
Tim9-F1/2mut - 
- Tim10-F3 
Tim9-F1/2mut Tim10-F3 
Table 7 – BY4741 S. cerevisiae strains produced containing either the F/1 (or 
F1/2mut) dihydrofolate reductase (DHFR) fragment, the F3 DHFR fragment or 
both. F1/2 refers to DHFR fragment 1 and F3 to DHFR fragment 2.	
 
As Tim9 and Tim10 are known to interact and localise to the IMS, the S. cerevisiae 
strain containing both vectors was used as a positive control for the assay. Specific 
targeting sequences – such as Cytochrome b2 (Cytb2) – that localise to the IMS 
could also have been used to further ensure correction localisation of the fusion 
proteins, though this will be discussed later. The Tim9-F1/2mut+Tim10-F3 strain 
was grown both as yeast cell cultures containing MTX and as spot-tests on MTX-
containing plates, though neither of these experiments gave the expected results 
in terms of cell growth. The growth of the Tim9-F1/2mut+Tim10-F3 strain was 
expected to be better in the presence of MTX than that of the F1/2+F3 strain it 
was compared to, but this was not observed (Appendix Table 1). The 
concentration of MTX used for these growth experiments was 200µg/ml, as was 
used by Tarassov et al., and yeast cell cultures were grown for at least 4 days in 
the presence of MTX as in their approach (Tarassov et al., 2008). As the approach 
taken in this study was different to that of Tarassov et al. and used yeast 
expression vectors, it is possible that the concentration of MTX must be adjusted 
for the split-DHFR assay to be successful. A range of different concentrations of 
MTX could be used to establish an upper limit at which neither the Tim9-
F1/2mut+Tim10-F3 strain or the F1/2+F3 strain are able to grow in the presence 
of MTX, as well as a lower limit at which both strains are able to grow. Further 
yeast culture growth experiments carried out in this way would allow optimisation 
of the concentration of MTX required for growth of strains containing the MTX-
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resistant split-DHFR plasmids. Similarly, as the focus was on the use of the split-
DHFR assay for IMS proteins, it is possible that the assay may not be useable for 
such proteins due to incorrect localisation of, for example, Tim9 or Tim10, due to 
the addition of the C-terminal DHFR fragment.  
4.2 Problems 
Several setbacks were faced when setting up the split-DHFR assay, and not all of 
the work could be completed due to time constraints. Mutation of the DHFR-F1/2 
fragment to produce the F1/2mut plasmid was delayed due to a random, single-
point mutation in the F1/2 fragment that inserted a stop codon (TAG) into the 
sequence (Appendix Figure 4) by mutation of thymine to adenine at position 108. 
This was corrected using mutagenesis PCR primers, as was initially used to 
generate the mutated form of F1/2 (Appendix Figure 5). Similarly, a problem was 
found in that the pRS415 vector used could not be sequenced correctly, and so a 
new, empty pRS415 vector (Appendix Figure 3) had to be ordered. This caused a 
severe delay in experimental work, as the pRS415 plasmid had to be cloned again 
from the initial stages and also re-transformed into BY4741 strains for use in later 
experiments. Although Tim9 and Tim10 were the only two mitochondrial proteins 
which were successfully cloned into DHFR fragment vectors, Gpx3 (which has a 
dual localisation in the cytosol and the IMS) was also cloned and sequenced 
(Appendix Figure 9). Gpx3, however, had three single-point mutations at the 
beginning of its sequence (positions 35, 50 and 124 in Appendix Figure 9) and so 
was deemed unusable for further experimentation at this stage. If more time had 
been available, it is likely that Gpx3 would have been either successfully re-cloned 
or that these mutations would have been corrected by mutagenesis PCR. The 
initial PCR to create the initial Mia40 insert proved difficult and took several 
attempts. It was thought that the lack of success in creating the Mia40 and Yap1 
clones may have been due to the size of the insert in comparison with Tim9, Tim10 
and Gpx3, and that further work would be needed to clone these two proteins 
successfully. 
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4.3 Future Experimental Work 
Ideally, the next step in experimental work would be to finish cloning Mia40, Gpx3 
and Yap1 into DHFR fragment yeast expression vectors, and then transform these 
into BY4741 S. cerevisiae strains as with Tim9 and Tim10. This would allow for the 
split-DHFR assay to be set up fully with known interacting and non-interacting 
proteins before its use in the study of putative PPIs. The exact MTX conditions 
required for the growth of yeast cells containing split-DHFR assay must also be set 
up, as mentioned previously. The DHFR fragments could then be used alongside 
other, in vitro techniques such as AP/MS to study the PPIs of mitochondrial 
proteins in a native cellular context. 
In the case of Tim9-F1/2mut+Tim10-F3, mitochondrial protein extracts could be 
taken from yeast cells expressing both plasmids and ran on a denaturing protein 
gel. Using antibodies for DHFR and/or Tim9 or Tim10 (which are available in the 
lab) would allow observation of whether the correct DHFR+Tim9Tim10 complex is 
present, as each TIM9/10 complex contains a heterohexamer of Tim9 and Tim10 
(Webb et al., 2006), and therefore 3 complete DHFR proteins. 
If the split-DHFR assay is shown to be functional, the same approach could then 
be used to determine the route of entry for proteins that interact in the IMS 
(Figure 9). This would be carried out by fusing two, interacting proteins of interest 
to each of the constructed DHFR fragments, and expressing these fragments in 
deletion yeast strains. Each knockout (K.O.) yeast strain would have a deletion of 
a gene expressing a protein involved in mitochondrial protein import (e.g. Tom70 
of the TOM complex). If the two DHFR-fused proteins are able to enter the IMS 
and interact, the yeast cells will grow. If they are unable to grow in a particular 
deletion strain, this means that the deleted gene was somehow involved in the 
import of the protein. This would allow for protein import components or 
chaperones involved in this process to be discovered. This could be carried out, 
for example, with Trr1-F1/2mut and Trx1-Cytb2-F3 in a strain with no native Trx1. 
The Cytb2 targeting sequence would anchor the Trx1 to the IM, ensuring that Trx1 
would definitely be present in the IMS. This would allow the import of Trr1 to be 
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assessed, as reconstitution of the DHFR fragments would depend on its import to 
the IMS and interaction with Trx. 
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Appendix 
Appendix Figure 1 – Sequence of murine dihydrofolate reductase (mDHFR) used, 
showing the F1/2 (green) and F3 (blue) domains, created using SnapGene. 
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Appendix Figure 2 – pRS316 plasmid, created using SnapGene. Contains ampicillin 
resistance (AmpR; green) and an uracil marker (URA3; orange) for growth on 
selective media. 
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Appendix Figure 3 – pRS415 plasmid, created using SnapGene. Contains ampicillin 
resistance (AmpR; green) and a leucine marker (LEU2; orange) for growth on 
selective media. 
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Appendix Figure 4 – pRS316-F1/2 aligned with murine dihydrofolate reductase 
fragment 1 (DHFR-F1/2). 
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Appendix Figure 5 – pRS316-F1/2mut aligned with murine dihydrofolate reductase 
fragment 1 (DHFR-F1/2). F1/2mut refers to the mutated methotrexate (MTX) 
resistant DHFR-F1/2. 
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Appendix Figure 6 – pRS416-F3 aligned with murine dihydrofolate reductase 
fragment 2 (DHFR-F3). 
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Appendix Figure 7 – pRS316-Tim9-F1/2mut aligned with S. cerevisiae Tim9. 
F1/2mut refers to the mutated methotrexate (MTX) resistant fragment 1 of 
dihydrofolate reductase (DHFR). 
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Appendix Figure 8 – pRS415-Tim10-F3 aligned with S. cerevisiae Tim10. F3 refers 
to fragment 2 of dihydrofolate reductase (DHFR). 
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Appendix Figure 9 – pRS415-Gpx3-F3 aligned with S. cerevisiae Gpx3. F3 refers to 
fragment 2 of dihydrofolate reductase (DHFR). 
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DHFR	Fragments	 OD	at	Specific	Time	Intervals	(Hours)	
F1/2	 F3	 0	 +1	 +6	 +21	 +24	 +24	 +24	 +24	 +24	 +24	
Tim9-F1/2mut	 Tim10-F3	 2.8	 0.66	 1.35	 2.14	 0.52	 0.63	 0.61	 0.9	 1.24	 1.5	
Tim9-F1/2mut	 F3	 2.9	 0.69	 1.88	 1.78	 0.94	 0.64	 0.66	 1.06	 1.36	 1.39	
F1/2mut	 F3	 2.8	 0.87	 1.62	 2.44	 0.69	 0.58	 0.73	 1.19	 1.31	 1.48	
F1/2	 F3	 2.8	 0.6	 1.37	 2.38	 0.56	 0.82	 0.73	 1.32	 1.26	 1.36	
Appendix Table 1 – Raw data of growth of S. cerevisiae cells containing split-
dihydrofolate reductase (DHFR) plasmids. These plasmids contained DHFR either 
the first (F1/2), second (F3) or mutated first (F1/2mut) fragment of DHFR. 
pRS316 was used as a vector for F1/2 or F1/2mut and pRS415 as a vector for F3. 
 
  
 62 
Bibliography 
Abe, Y., Shodai, T., Muto, T., Mihara, K., Torii, H., Nishikawa, S., … Kohda, D. 
(2000). Structural basis of presequence recognition by the mitochondrial 
protein import receptor Tom20. Cell, 100(5), 551–560. 
Bauer, M. F., Hofmann, S., Neupert, W., & Brunner, M. (2000). Protein 
translocation into mitochondria: the role of TIM complexes. Trends in Cell 
Biology, 10(1), 25–31. 
Beverly, K. N., Sawaya, M. R., Schmid, E., & Koehler, C. M. (2008). The Tim8-
Tim13 Complex Has Multiple Substrate Binding Sites and Binds Cooperatively 
to Tim23. Journal of Molecular Biology, 382(5), 1144–1156. 
http://doi.org/10.1016/j.jmb.2008.07.069 
Bohnert, M., Rehling, P., Guiard, B., Herrmann, J. M., Pfanner, N., & van der 
Laan, M. (2010). Cooperation of stop-transfer and conservative sorting 
mechanisms in mitochondrial protein transport. Current Biology, 20(13), 
1227–1232. 
Brachmann, C. B., Davies, A., Cost, G. J., Caputo, E., Li, J., Hieter, P., & 
Boeke, J. D. (1998). Designer deletion strains derived from Saccharomyces 
cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene 
disruption and other applications. YEAST-CHICHESTER-, 14, 115–132. 
Braun, H.-P., & Schmitz, U. K. (1997). The mitochondrial processing peptidase. 
The International Journal of Biochemistry & Cell Biology, 29(8–9), 1043–
1045. 
Brogden, R. N., Carmine, A. A., Heel, R. C., Speight, T. M., & Avery, G. S. 
(1982). Trimethoprim: a review of its antibacterial activity, 
pharmacokinetics and therapeutic use in urinary tract infections. Drugs, 
23(6), 405–430. 
Buchwalder, A., Szadkowski, H., & Kirschner, K. (1992). A fully active variant of 
dihydrofolate reductase with a circularly permuted sequence. Biochemistry, 
31(6), 1621–1630. 
Chae, H. Z., Chung, S. J., & Rhee, S. G. (1994). Thioredoxin-dependent peroxide 
reductase from yeast. Journal of Biological Chemistry, 269(44), 27670–
27678. 
Chae, H. Z., & Rhee, S. G. (1994). A thiol-specific antioxidant and sequence 
homology to various proteins of unknown function. BioFactors, 4(3–4), 177–
 63 
180. 
Chan, N. C., Likić, V. A., Waller, R. F., Mulhern, T. D., & Lithgow, T. (2006). 
The C-terminal TPR Domain of Tom70 Defines a Family of Mitochondrial 
Protein Import Receptors Found only in Animals and Fungi. Journal of 
Molecular Biology, 358(4), 1010–1022. 
http://doi.org/10.1016/j.jmb.2006.02.062 
Chatzi, A., Manganas, P., & Tokatlidis, K. (2016). Oxidative folding in the 
mitochondrial intermembrane space: A regulated process important for cell 
physiology and disease. Biochimica et Biophysica Acta - Molecular Cell 
Research, 1863(6), 1298–1306. 
http://doi.org/10.1016/j.bbamcr.2016.03.023 
Chatzi, A., Sideris, D. P., Katrakili, N., Pozidis, C., & Tokatlidis, K. (2013). 
Biogenesis of yeast Mia40–uncoupling folding from import and atypical 
recognition features. FEBS Journal, 280(20), 4960–4969. 
Chatzi, A., & Tokatlidis, K. (2013). The mitochondrial intermembrane space: A 
hub for oxidative folding linked to protein biogenesis. Antioxidants & Redox 
Signaling, 19(1), 54–62. 
Chung, H. S., Wang, S.-B., Venkatraman, V., Murray, C. I., & Van Eyk, J. E. 
(2013). Cysteine oxidative posttranslational modifications emerging 
regulation in the cardiovascular system. Circulation Research, 112(2), 382–
392. 
Consortium, U. (2017). UniProt: the universal protein knowledgebase. Nucleic 
Acids Research, 45(D1), D158–D169. 
Davey, K. M., Parboosingh, J. S., McLeod, D. R., Chan, A., Casey, R., Ferreira, 
P., … Bernier, F. P. (2006). Mutation of DNAJC19, a human homologue of 
yeast inner mitochondrial membrane co-chaperones, causes DCMA 
syndrome, a novel autosomal recessive Barth syndrome-like condition. 
Journal of Medical Genetics, 43(5), 385–393. 
Dekker, P. J., Ryan, M. T., Brix, J., Muller, H., Honlinger, A., & Pfanner, N. 
(1998). Preprotein translocase of the outer mitochondrial membrane: 
molecular dissection  and assembly of the general import pore complex. 
Molecular and Cellular Biology, 18(11), 6515–6524. 
Delaunay, A., Pflieger, D., Barrault, M.-B., Vinh, J., & Toledano, M. B. (2002). A 
thiol peroxidase is an H2O2 receptor and redox-transducer in gene 
activation. Cell, 111(4), 471–481. 
 64 
Dietmeier, K., Honlinger, A., Bomer, U., Dekker, P. J., Eckerskorn, C., 
Lottspeich, F., … Pfanner, N. (1997). Tom5 functionally links mitochondrial 
preprotein receptors to the general import  pore. Nature, 388(6638), 195–
200. http://doi.org/10.1038/40663 
Eckers, E., Bien, M., Stroobant, V., Herrmann, J. M., & Deponte, M. (2009). 
Biochemical characterization of dithiol glutaredoxin 8 from Saccharomyces 
cerevisiae: the catalytic redox mechanism redux. Biochemistry, 48(6), 1410–
1423. 
Ercikan-Abali, E. A., Waltham, M. C., Dicker, A. P., Schweitzer, B. I., Gritsman, 
H., Banerjee, D., & Bertino, J. R. (1996). Variants of human dihydrofolate 
reductase with substitutions at leucine-22: effect on catalytic and inhibitor 
binding properties. Molecular Pharmacology, 49(3), 430–437. Retrieved from 
http://molpharm.aspetjournals.org/content/49/3/430.abstract 
Fields, S., & Song, O. (1989). A novel genetic system to detect protein–-protein 
interactions. Nature, 340(6230), 245–246. http://doi.org/10.1038/340245a0 
Fraga, H., & Ventura, S. (2013). Oxidative folding in the mitochondrial 
intermembrane space in human health and disease. International Journal of 
Molecular Sciences, 14(2), 2916–2927. 
Gabriel, K., Milenkovic, D., Chacinska, A., Müller, J., Guiard, B., Pfanner, N., & 
Meisinger, C. (2007). Novel mitochondrial intermembrane space proteins as 
substrates of the MIA import pathway. Journal of Molecular Biology, 365(3), 
612–620. 
Galarneau, A., Primeau, M., Trudeau, L.-E., & Michnick, S. W. (2002). [beta]-
Lactamase protein fragment complementation assays as in vivo and in vitro 
sensors of protein-protein interactions. Nature Biotechnology, 20(6), 619–
622. Retrieved from http://dx.doi.org/10.1038/nbt0602-619 
Gaur, R. K. (2014). Amino acid frequency distribution among eukaryotic 
proteins. The IIOAB Journal, 5(2), 6. 
Geissler, A., Chacinska, A., Truscott, K. N., Wiedemann, N., Brandner, K., 
Sickmann, A., … Rehling, P. (2002). The mitochondrial presequence 
translocase: an essential role of Tim50 in directing preproteins to the import 
channel. Cell, 111(4), 507–518. 
Gerashchenko, M. V, Lobanov, A. V, & Gladyshev, V. N. (2012). Genome-wide 
ribosome profiling reveals complex translational regulation in response to 
oxidative stress. Proceedings of the National Academy of Sciences, 109(43), 
 65 
17394–17399. 
Gietz, R. D., & Schiestl, R. H. (1995). Transforming yeast with DNA. Methods in 
Molecular and Cellular Biology, 5(5), 255–269. 
Gingras, A.-C., Gstaiger, M., Raught, B., & Aebersold, R. (2007). Analysis of 
protein complexes using mass spectrometry. Nature Reviews Molecular Cell 
Biology, 8(8), 645–654. 
Glick, B. S., Beasley, E. M., & Schatz, G. (1992). Protein sorting in mitochondria. 
Trends in Biochemical Sciences, 17(11), 453–459. 
Grant, C. M. (2001). Role of the glutathione/glutaredoxin and thioredoxin 
systems in yeast growth and response to stress conditions. Molecular 
Microbiology, 39(3), 533–541. 
Greetham, D., Kritsiligkou, P., Watkins, R. H., Carter, Z., Parkin, J., & Grant, C. 
M. (2013). Oxidation of the yeast mitochondrial thioredoxin promotes cell 
death. Antioxidants & Redox Signaling, 18(4), 376–385. 
Hansen, R. E., Otsu, M., Braakman, I., & Winther, J. R. (2013). Quantifying 
changes in the cellular thiol-disulfide status during differentiation of B cells 
into antibody-secreting plasma cells. International Journal of Cell Biology, 
2013. 
Hasson, S. a, Damoiseaux, R., Glavin, J. D., Dabir, D. V, Walker, S. S., & 
Koehler, C. M. (2010). Substrate specificity of the TIM22 mitochondrial 
import pathway revealed with small molecule inhibitor of protein 
translocation. Proceedings of the National Academy of Sciences of the 
United States of America, 107(21), 9578–9583. 
http://doi.org/10.1073/pnas.0914387107 
Hildenbeutel, M., Theis, M., Geier, M., Haferkamp, I., Neuhaus, H. E., 
Herrmann, J. M., & Ott, M. (2012). The membrane insertase Oxa1 is 
required for efficient import of carrier proteins into mitochondria. Journal 
of Molecular Biology, 423(4), 590–599. 
Hillman, M. C., Yang, L. S., Sun, S., Duke, J. L., O’Neil, K. T., Kochie, J. E., … 
Murphy, K. (2001). A comprehensive system for protein purification and 
biochemical analysis based on antibodies to c-myc peptide. Protein 
Expression and Purification, 23(2), 359–368. 
Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S.-L., … 
Boutilier, K. (2002). Systematic identification of protein complexes in 
Saccharomyces cerevisiae by mass spectrometry. Nature, 415(6868), 180–
 66 
183. 
Holmgren, A. (1989). Thioredoxin and glutaredoxin systems. J Biol Chem, 
264(24), 13963–13966. 
Hu, C.-D., & Kerppola, T. K. (2003). Simultaneous visualization of multiple 
protein interactions in living cells using multicolor fluorescence 
complementation analysis. Nature Biotechnology, 21(5), 539–545. 
http://doi.org/10.1038/nbt816 
Huh, W.-K., Falvo, J. V, Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, 
J. S., & O’Shea, E. K. (2003). Global analysis of protein localization in 
budding yeast. Nature, 425(6959), 686–691. 
http://doi.org/10.1038/nature02026 
Ieva, R., Schrempp, S. G., Opaliński, Ł., Wollweber, F., Höß, P., Heißwolf, A. K., 
… vanderLaan, M. (2014). Mgr2 functions as lateral gatekeeper for 
preprotein sorting in the mitochondrial inner membrane. Molecular Cell, 
56(5), 641–652. http://doi.org/10.1016/j.molcel.2014.10.010 
Ikon, N., & Ryan, R. O. (2017). Cardiolipin and mitochondrial cristae 
organization. Biochimica et Biophysica Acta, 1859(6), 1156–1163. 
http://doi.org/10.1016/j.bbamem.2017.03.013 
Inoue, Y., Matsuda, T., Sugiyama, K., Izawa, S., & Kimura, A. (1999). Genetic 
analysis of glutathione peroxidase in oxidative stress response of 
Saccharomyces cerevisiae. Journal of Biological Chemistry, 274(38), 27002–
27009. 
Israel, D. I., & Kaufman, R. J. (1993). Dexamethasone negatively regulates the 
activity of a chimeric dihydrofolate reductase/glucocorticoid receptor 
protein. Proceedings of the National Academy of Sciences, 90(9), 4290–
4294. Retrieved from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC46492/ 
Izquierdo, A., Casas, C., Mühlenhoff, U., Lillig, C. H., & Herrero, E. (2008). 
Saccharomyces cerevisiae Grx6 and Grx7 are monothiol glutaredoxins 
associated with the early secretory pathway. Eukaryotic Cell, 7(8), 1415–
1426. 
Jensen, R. E., & Johnson, A. E. (2001). Opening the door to mitochondrial 
protein import. Nature Structural & Molecular Biology, 8(12), 1008–1010. 
Kaihara, A., Kawai, Y., Sato, M., Ozawa, T., & Umezawa, Y. (2003). Locating a 
protein-protein interaction in living cells via split Renilla luciferase 
 67 
complementation. Analytical Chemistry, 75(16), 4176–4181. 
http://doi.org/10.1021/ac0300800 
Kerppola, T. K. (2006). Visualization of molecular interactions by fluorescence 
complementation. Nature Reviews Molecular Cell Biology, 7(6), 449–456. 
http://doi.org/10.1038/nrm1929 
Kerscher, O., Holder, J., Srinivasan, M., Leung, R. S., & Jensen, R. E. (1997). 
The Tim54p-Tim22p complex mediates insertion of proteins into the 
mitochondrial inner membrane. The Journal of Cell Biology, 139(7), 1663–
1675. 
Kojer, K., Bien, M., Gangel, H., Morgan, B., Dick, T. P., & Riemer, J. (2012). 
Glutathione redox potential in the mitochondrial intermembrane space is 
linked to the cytosol and impacts the Mia40 redox state. The EMBO Journal, 
31(14), 3169–3182. 
Kojer, K., Peleh, V., Calabrese, G., Herrmann, J. M., & Riemer, J. (2015). 
Kinetic control by limiting glutaredoxin amounts enables thiol oxidation in 
the reducing mitochondrial intermembrane space. Molecular Biology of the 
Cell, 26(2), 195–204. 
Kovermann, P., Truscott, K. N., Guiard, B., Rehling, P., Sepuri, N. B., Muller, 
H., … Pfanner, N. (2002). Tim22, the essential core of the mitochondrial 
protein insertion complex, forms a voltage-activated and signal-gated 
channel. Molecular Cell, 9(2), 363–373. 
Kozany, C., Mokranjac, D., Sichting, M., Neupert, W., & Hell, K. (2004). The J 
domain–related cochaperone Tim16 is a constituent of the mitochondrial 
TIM23 preprotein translocase. Nature Structural & Molecular Biology, 11(3), 
234–241. 
Kritsiligkou, P., Chatzi, A., Charalampous, G., Mironov, A., Grant, C. M., & 
Tokatlidis, K. (2017). Unconventional Targeting of a Thiol Peroxidase to the 
Mitochondrial Intermembrane Space Facilitates Oxidative Protein Folding. 
Cell Reports, 18(11), 2729–2741. 
Li, Y., Dudek, J., Guiard, B., Pfanner, N., Rehling, P., & Voos, W. (2004). The 
presequence translocase-associated protein import motor of mitochondria 
Pam16 functions in an antagonistic manner to Pam18. Journal of Biological 
Chemistry, 279(36), 38047–38054. 
Lichty, J. J., Malecki, J. L., Agnew, H. D., Michelson-Horowitz, D. J., & Tan, S. 
(2005). Comparison of affinity tags for protein purification. Protein 
 68 
Expression and Purification, 41(1), 98–105. 
Lodish, H., Berk, A., Zipursky, S. L., Matsudaira, P., Baltimore, D., & Darnell, J. 
(2000). Molecular cell biology 4th edition. National Center for 
Biotechnology InformationÕs Bookshelf. 
Longen, S., Bien, M., Bihlmaier, K., Kloeppel, C., Kauff, F., Hammermeister, M., 
… Riemer, J. (2009). Systematic analysis of the twin cx9c protein family. 
Journal of Molecular Biology, 393(2), 356–368. 
Luikenhuis, S., Perrone, G., Dawes, I. W., & Grant, C. M. (1998). The yeast 
Saccharomyces cerevisiae contains two glutaredoxin genes that are required 
for protection against reactive oxygen species. Molecular Biology of the 
Cell, 9(5), 1081–1091. 
MacPherson, L., & Tokatlidis, K. (2017). Protein trafficking in the mitochondrial 
intermembrane space: mechanisms and links to human disease. Biochemical 
Journal, 474(15), 2533–2545. 
Manganas, P., MacPherson, L., & Tokatlidis, K. (2017). Oxidative protein 
biogenesis and redox regulation in the mitochondrial intermembrane space. 
Cell and Tissue Research, 367(1), 43–57. 
Mesecke, N., Spang, A., Deponte, M., & Herrmann, J. M. (2008). A novel group 
of glutaredoxins in the cis-Golgi critical for oxidative stress resistance. 
Molecular Biology of the Cell, 19(6), 2673–2680. 
Michnick, S. W., Ear, P. H., Landry, C., Malleshaiah, M. K., & Messier, V. (2010). 
A Toolkit of Protein-Fragment Complementation Assays for Studying and 
Dissecting Large-Scale and Dynamic Protein–Protein Interactions in Living 
Cells. Methods in Enzymology (2nd ed., Vol. 470). Elsevier Inc. 
http://doi.org/10.1016/S0076-6879(10)70014-8 
Michnick, S. W., & Remy, I. (1999). Clonal selection and in vivo quantitation of 
protein interactions with protein-fragment complementation assays. 
Proceedings of the National Academy of Sciences, 96(10), 5394–5399. 
http://doi.org/10.1073/pnas.96.10.5394 
Miranda-Vizuete, A., Damdimopoulos, A. E., & Spyrou, G. (2000). The 
mitochondrial thioredoxin system. Antioxidants & Redox Signaling, 2(4), 
801–810. 
Mokranjac, D., Paschen, S. A., Kozany, C., Prokisch, H., Hoppins, S. C., Nargang, 
F. E., … Hell, K. (2003). Tim50, a novel component of the TIM23 preprotein 
translocase of mitochondria. The EMBO Journal, 22(4), 816–825. 
 69 
Moon, J.-M., Kim, G.-Y., & Rhim, H. (2012). A new idea for simple and rapid 
monitoring of gene expression: requirement of nucleotide sequences 
encoding an N-terminal HA tag in the T7 promoter-driven expression in E. 
coli. Biotechnology Letters, 34(10), 1841–1846. 
Morano, K. A., Grant, C. M., & Moye-Rowley, W. S. (2012). The response to heat 
shock and oxidative stress in Saccharomyces cerevisiae. Genetics, 190(4), 
1157–1195. 
Morell, M., Ventura, S., & Avilés, F. X. (2009). Protein complementation assays: 
Approaches for the in vivo analysis of protein interactions. FEBS Letters, 
583(11), 1684–1691. http://doi.org/10.1016/j.febslet.2009.03.002 
Mühlenhoff, U., Molik, S., Godoy, J. R., Uzarska, M. A., Richter, N., Seubert, A., 
… Herrero, E. (2010). Cytosolic monothiol glutaredoxins function in 
intracellular iron sensing and trafficking via their bound iron-sulfur cluster. 
Cell Metabolism, 12(4), 373–385. 
Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. 
Biochemical Journal, 417(1), 1–13. 
Nesvizhskii, A. I. (2010). A survey of computational methods and error rate 
estimation procedures for peptide and protein identification in shotgun 
proteomics. Journal of Proteomics, 73(11), 2092–2123. 
Nesvizhskii, A. I. (2012). Computational and informatics strategies for 
identification of specific protein interaction partners in affinity purification 
mass spectrometry experiments. Proteomics, 12(10), 1639–1655. 
http://doi.org/10.1002/pmic.201100537 
Neupert, W., & Herrmann, J. M. (2007). Translocation of proteins into 
mitochondria. Annual Review of Biochemistry, 76, 723–749. 
http://doi.org/10.1146/annurev.biochem.76.052705.163409 
Paschen, S. A., Rothbauer, U., Kaldi, K., Bauer, M. F., Neupert, W., & Brunner, 
M. (2000). The role of the TIM8-13 complex in the import of Tim23 into 
mitochondria. The EMBO Journal, 19(23), 6392–6400. 
http://doi.org/10.1093/emboj/19.23.6392 
Pedrajas, J. R., Kosmidou, E., Miranda-Vizuete, A., Gustafsson, J.-Å., Wright, A. 
P. H., & Spyrou, G. (1999). Identification and functional characterization of 
a novel mitochondrial thioredoxin system in Saccharomyces cerevisiae. 
Journal of Biological Chemistry, 274(10), 6366–6373. 
Pelletier, J. N., Arndt, K. M., Plückthun, A., & Michnick, S. W. (1999). An in vivo 
 70 
library-versus-library selection of optimized protein–protein interactions. 
Nature Biotechnology, 17(7), 683–690. http://doi.org/10.1038/10897 
Pelletier, J. N., Campbell-Valois, F.-X., & Michnick, S. W. (1998). 
Oligomerization domain-directed reassembly of active dihydrofolate 
reductase from rationally designed fragments. Proceedings of the National 
Academy of Sciences, 95(21), 12141–12146. 
http://doi.org/10.1073/pnas.95.21.12141 
Perotti, M. E., Anderson, W. A., & Swift, H. (1983). Quantitative cytochemistry 
of the diaminobenzidine cytochrome oxidase reaction product in 
mitochondria of cardiac muscle and pancreas. The Journal of 
Histochemistry and Cytochemistry : Official Journal of the Histochemistry 
Society, 31(3), 351–365. http://doi.org/10.1177/31.3.6186730 
Rehling, P. (2003). Protein Insertion into the Mitochondrial Inner Membrane by a 
Twin-Pore Translocase. Science, 299(5613), 1747–1751. 
http://doi.org/10.1126/science.1080945 
Rehling, P., Brandner, K., & Pfanner, N. (2004). Mitochondrial import and the 
twin-pore translocase. Nature Reviews Molecular Cell Biology, 5(7), 519–
530. 
Remy, I., Campbell-Valois, F.-X., & Michnick, S. W. (2007). Detection of protein–
protein interactions using a simple survival protein-fragment 
complementation assay based on the enzyme dihydrofolate reductase. 
Nature Protocols, 2(9), 2120–2125. http://doi.org/10.1038/nprot.2007.266 
Riemer, J., Fischer, M., & Herrmann, J. M. (2011). Oxidation-driven protein 
import into mitochondria: Insights and blind spots. Biochimica et Biophysica 
Acta (BBA)-Biomembranes, 1808(3), 981–989. 
Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., & Séraphin, B. (1999). 
A generic protein purification method for protein complex characterization 
and proteome exploration. Nature Biotechnology, 17(10), 1030–1032. 
Rodrıguez-Manzaneque, M. T., Tamarit, J., Bellı,́ G., Ros, J., & Herrero, E. 
(2002). Grx5 is a mitochondrial glutaredoxin required for the activity of 
iron/sulfur enzymes. Molecular Biology of the Cell, 13(4), 1109–1121. 
Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S. A., Mannella, C. A., & 
Korsmeyer, S. J. (2002). A distinct pathway remodels mitochondrial cristae 
and mobilizes cytochrome c during apoptosis. Developmental Cell, 2(1), 55–
67. 
 71 
Sherman, E. L., Go, N. E., & Nargang, F. E. (2005). Functions of the small 
proteins in the TOM complex of Neurospora crasssa. Molecular Biology of 
the Cell, 16(9), 4172–4182. http://doi.org/10.1091/mbc.E05-03-0187 
Shibasaki, S., Sakata, K., Ishii, J., Kondo, A., & Ueda, M. (2008). Development of 
a yeast protein fragment complementation assay (PCA) system using 
dihydrofolate reductase (DHFR) with specific additives. Applied 
Microbiology and Biotechnology, 80(4), 735–743. 
http://doi.org/10.1007/s00253-008-1624-x 
Shiota, T., Imai, K., Qiu, J., Hewitt, V. L., Tan, K., Shen, H.-H., … Kamiya, M. 
(2015). Molecular architecture of the active mitochondrial protein gate. 
Science, 349(6255), 1544–1548. 
Sickmann, A., Reinders, J., Wagner, Y., Joppich, C., Zahedi, R., Meyer, H. E., … 
Guiard, B. (2003). The proteome of Saccharomyces cerevisiae mitochondria. 
Proceedings of the National Academy of Sciences, 100(23), 13207–13212. 
Sideris, D. P., & Tokatlidis, K. (2007). Oxidative folding of small Tims is 
mediated by site-specific docking onto Mia40 in the mitochondrial 
intermembrane space. Molecular Microbiology, 65(5), 1360–1373. 
Sideris, D. P., & Tokatlidis, K. (2010). Oxidative protein folding in the 
mitochondrial intermembrane space. Antioxidants & Redox Signaling, 13(8), 
1189–1204. 
Smith, D. B., & Johnson, K. S. (1988). Single-step purification of polypeptides 
expressed in Escherichia coli as fusions with glutathione S-transferase. 
Gene, 67(1), 31–40. 
Subramaniam, R., Desveaux, D., Spickler, C., Michnick, S. W., & Brisson, N. 
(2001). Direct visualization of protein interactions in plant cells. Nature 
Biotechnology, 19(8), 769–772. http://doi.org/10.1038/90831 
Tarassov, K., Messier, V., Landry, C. R., Radinovic, S., Serna Molina, M. M., 
Shames, I., … Michnick, S. W. (2008). An in Vivo Map of the Yeast Protein 
Interactome. Science, 320(5882), 1465–1470. 
http://doi.org/10.1126/science.1153878 
Thillet, J., Absil, J., Stone, S. R., & Pictet, R. (1988). Site-directed mutagenesis 
of mouse dihydrofolate reductase. Mutants with increased resistance to 
methotrexate and trimethoprim. Journal of Biological Chemistry, 263(25), 
12500–12508. 
Ting, S. Y., Schilke, B. A., Hayashi, M., & Craig, E. A. (2014). Architecture of the 
 72 
TIM23 inner mitochondrial translocon and interactions with the matrix 
import motor. Journal of Biological Chemistry, 289(41), 28689–28696. 
http://doi.org/10.1074/jbc.M114.588152 
Tokatlidis, K. (2016). Unpublished data. University of Glasgow. 
Trinkle-Mulcahy, L., Boulon, S., Lam, Y. W., Urcia, R., Boisvert, F.-M., 
Vandermoere, F., … Leonhardt, H. (2008). Identifying specific protein 
interaction partners using quantitative mass spectrometry and bead 
proteomes. The Journal of Cell Biology, 183(2), 223–239. 
Trotter, E. W., & Grant, C. M. (2002). Thioredoxins are required for protection 
against a reductive stress in the yeast Saccharomyces cerevisiae. Molecular 
Microbiology, 46(3), 869–878. 
Trotter, E. W., & Grant, C. M. (2005). Overlapping roles of the cytoplasmic and 
mitochondrial redox regulatory systems in the yeast Saccharomyces 
cerevisiae. Eukaryotic Cell, 4(2), 392–400. 
Ulrich, E. L., Akutsu, H., Doreleijers, J. F., Harano, Y., Ioannidis, Y. E., Lin, J., 
… Miller, Z. (2007). BioMagResBank. Nucleic Acids Research, 36(suppl_1), 
D402–D408. 
Urlaub, G., & Chasin, L. A. (1980). Isolation of Chinese hamster cell mutants 
deficient in dihydrofolate reductase activity. Proceedings of the National 
Academy of Sciences of the United States of America, 77(7), 4216–4220. 
Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC349802/ 
Urlaub, G., Käs, E., Carothers, A. M., & Chasin, L. A. (1983). Deletion of the 
diploid dihydrofolate reductase locus from cultured mammalian cells. Cell, 
33(2), 405–412. 
van Wilpe, S., Ryan, M. T., Hill, K., Maarse, A. C., Meisinger, C., Brix, J., … 
Meijer, M. (2000). erratum: Tom22 is a multifunctional organizer of the 
mitochondrial preprotein translocase. Nature, 408(6812), 616. 
Villalobos, V., Naik, S., & Piwnica-Worms, D. (2007). Current State of Imaging 
Protein-Protein Interactions In Vivo with Genetically Encoded Reporters. 
Annual Review of Biomedical Engineering, 9(1), 321–349. 
http://doi.org/10.1146/annurev.bioeng.9.060906.152044 
Vögtle, F.-N., Burkhart, J. M., Rao, S., Gerbeth, C., Hinrichs, J., Martinou, J.-
C., … Meisinger, C. (2012). Intermembrane space proteome of yeast 
mitochondria. Molecular & Cellular Proteomics, 11(12), 1840–1852. 
Wagner, K., Gebert, N., Guiard, B., Brandner, K., Truscott, K. N., Wiedemann, 
 73 
N., … Rehling, P. (2008). The assembly pathway of the mitochondrial carrier 
translocase involves four preprotein translocases. Molecular and Cellular 
Biology, 28(13), 4251–4260. http://doi.org/10.1128/MCB.02216-07 
Webb, C. T., Gorman, M. A., Lazarou, M., Ryan, M. T., & Gulbis, J. M. (2006). 
Crystal structure of the mitochondrial chaperone TIM9.10 reveals a six-
bladed alpha-propeller. Molecular Cell, 21(1), 123–133. 
http://doi.org/10.1016/j.molcel.2005.11.010 
Wheeler, G. L., & Grant, C. M. (2004). Regulation of redox homeostasis in the 
yeast Saccharomyces cerevisiae. Physiologia Plantarum, 120(1), 12–20. 
Wood, M. J., Storz, G., & Tjandra, N. (2004). Structural basis for redox 
regulation of Yap1 transcription factor localization. Nature, 430(7002), 917–
921. 
Wu, C. C., & MacCoss, M. J. (2002). Shotgun proteomics: tools for the analysis of 
complex biological systems. Curr Opin Mol Ther, 4(3), 242–250. 
Yamamoto, H., Esaki, M., Kanamori, T., Tamura, Y., Nishikawa, S., & Endo, T. 
(2002). Tim50 is a subunit of the TIM23 complex that links protein 
translocation across the outer and inner mitochondrial membranes. Cell, 
111(4), 519–528. 
Zheng, S., & Kwon, I. (2013). Controlling enzyme inhibition using an expanded 
set of genetically encoded amino acids. Biotechnology and Bioengineering, 
110(9), 2361–2370. 
 
 
